id,label
HGNC:15894,PANK2
chembl:CHEMBL163316,3-O-METHYLQUERCETIN
chembl:CHEMBL266195,ALPRENOLOL
chembl:CHEMBL451930,PLITIDEPSIN
chembl:CHEMBL483,TENOFOVIR
chembl:CHEMBL523200,CHEMBL523200
chembl:CHEMBL601952,CHEMBL601952
chembl:CHEMBL1078000,CHEMBL1078000
chembl:CHEMBL23588,FLUFENAMIC ACID
MONDO:0013584,hereditary sensory neuropathy-deafness-dementia syndrome
chembl:CHEMBL547,ISOTRETINOIN
chembl:CHEMBL2103852,CROLIBULIN
chembl:CHEMBL468167,CHLOROTHALONIL
HGNC:17780,ACTBL2
chembl:CHEMBL402548,DANUSERTIB
chembl:CHEMBL6246,ELLAGIC ACID
chembl:CHEMBL27,PROPRANOLOL
MONDO:0010334,severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome
CHEBI:7735,olanzapine
HP:0002169,Clonus
chembl:CHEMBL518292,ISOVELLERAL
HP:0002530,Axial dystonia
HP:0002406,Limb dysmetria
HGNC:9154,PNKP
chembl:CHEMBL261131,DIACYLGLYCEROL KINASE INHIBITOR II
Reactome:R-DRE-500753,Pyrimidine biosynthesis
chembl:CHEMBL1337502,BENZO[B]FLUORANTHENE
chembl:CHEMBL451226,CHEMBL451226
chembl:CHEMBL2109447,LYM-1
chembl:CHEMBL412142,CHIR-99021
chembl:CHEMBL2104262,FADOLMIDINE
chembl:CHEMBL1088750,ARRY-797
chembl:CHEMBL67535,CHEMBL67535
chembl:CHEMBL1525,PERMETHRIN
chembl:CHEMBL77456,TYRPHOSTIN 1
chembl:CHEMBL2109092,EPOETIN BETA
chembl:CHEMBL334255,CETYLPYRIDINIUM BROMIDE
chembl:CHEMBL578905,CHEMBL578905
HGNC:728,ARVCF
chembl:CHEMBL1614710,OSI-930
chembl:CHEMBL234338,CHEMBL234338
chembl:CHEMBL3545097,SAPANISERTIB
chembl:CHEMBL32749,FERULIC ACID
chembl:CHEMBL603952,CHEMBL603952
chembl:CHEMBL354541,LOMITAPIDE
MONDO:0016318,progressive multifocal leukoencephalopathy
HP:0002072,Chorea
chembl:CHEMBL582286,CHEMBL582286
chembl:CHEMBL429405,SARCOLYSIN
chembl:CHEMBL243664,ACACETIN
chembl:CHEMBL1984884,CHEMBL1984884
chembl:CHEMBL1697744,ERDOSTEINE
chembl:CHEMBL680,CEFACLOR
chembl:CHEMBL672,FENOFIBRATE
chembl:CHEMBL17201,CHEMBL17201
chembl:CHEMBL1096896,UK432097
chembl:CHEMBL211670,CHEMBL211670
HP:0000738,Hallucinations
chembl:CHEMBL1905010,PYRAFLUFEN-ETHYL
HGNC:25751,TRAPPC11
chembl:CHEMBL941,IMATINIB
chembl:CHEMBL2103822,TASIMELTEON
chembl:CHEMBL576362,CHEMBL576362
chembl:CHEMBL1476605,CLOFOCTOL
MONDO:0011781,spinocerebellar ataxia type 17
chembl:CHEMBL3545308,ROCILETINIB
MONDO:0002413,glycogen storage disease I
chembl:CHEMBL502109,BENZALKONIUM CHLORIDE
chembl:CHEMBL1077773,CHEMBL1077773
chembl:CHEMBL1201182,TEMSIROLIMUS
chembl:CHEMBL336961,AZAKENPAULLONE
chembl:CHEMBL388590,BENZBROMARONE
chembl:CHEMBL576409,CHEMBL576409
HGNC:11005,SLC2A1
chembl:CHEMBL529,AZITHROMYCIN
chembl:CHEMBL306946,TRYPTANTHRIN
chembl:CHEMBL20562,ZAPA
chembl:CHEMBL6,INDOMETHACIN
chembl:CHEMBL932,DIPYRIDAMOLE
chembl:CHEMBL419667,RELCOVAPTAN
HGNC:6836,MAP1B
chembl:CHEMBL255044,FLUPIRTINE
HGNC:11425,STS
chembl:CHEMBL541388,FASUDIL HYDROCHLORIDE
chembl:CHEMBL78150,TYRPHOSTIN A9
chembl:CHEMBL4297850,XENTUZUMAB
chembl:CHEMBL2107759,MILATAXEL
HP:0007325,Generalized dystonia
HGNC:245,ADD3
chembl:CHEMBL27759,ENTINOSTAT
HP:0020045,Esodeviation
HGNC:9179,POLG
chembl:CHEMBL1489223,SAPPANONE A DIMETHYL ETHER
chembl:CHEMBL1518572,CHEMBL1518572
chembl:CHEMBL186113,GW-328267
Reactome:R-CFA-611105,Respiratory electron transport
HP:0001332,Dystonia
chembl:CHEMBL52885,ENMD-981693
HGNC:16235,DNAJC5
chembl:CHEMBL374107,8-AZAGUANINE
chembl:CHEMBL2107881,REGRAMOSTIM
HP:0002599,Head titubation
chembl:CHEMBL53463,DOXORUBICIN
chembl:CHEMBL1200765,SIBUTRAMINE HYDROCHLORIDE
chembl:CHEMBL591834,CHEMBL591834
CHEBI:9168,sirolimus
chembl:CHEMBL84,TOPOTECAN
chembl:CHEMBL796,METHYLPHENIDATE
chembl:CHEMBL669,CYCLOBENZAPRINE
chembl:CHEMBL331237,TRICIRIBINE
chembl:CHEMBL377300,BRIVANIB
chembl:CHEMBL9470,SHIKONIN
chembl:CHEMBL56337,EPALRESTAT
chembl:CHEMBL3184679,AZD-4547
chembl:CHEMBL1520188,CLODRONATE DISODIUM
chembl:CHEMBL1288830,SPINASAPONIN A METHYL ESTER
MONDO:0958012,neurodegeneration with brain iron accumulation 9
chembl:CHEMBL415049,BARASERTIB
HGNC:8607,PRKN
chembl:CHEMBL309760,CHEMBL309760
chembl:CHEMBL1201061,LEVALBUTEROL HYDROCHLORIDE
Reactome:R-DRE-390651,Dopamine receptors
MONDO:0005292,colitis
wikidata:Q47520887,ADRIAMYCIN
chembl:CHEMBL1043,DAPSONE
chembl:CHEMBL19236,MOXONIDINE
MONDO:0019792,autosomal dominant cerebellar ataxia type I
chembl:CHEMBL1451216,CHEMBL1451216
chembl:CHEMBL408,TROGLITAZONE
chembl:CHEMBL1200434,OXTRIPHYLLINE
chembl:CHEMBL483847,CHEMBL483847
chembl:CHEMBL1170485,CHEMBL1170485
chembl:CHEMBL3137336,UPROSERTIB
HGNC:7224,MPV17
HP:0000737,Irritability
chembl:CHEMBL295337,CHEMBL295337
chembl:CHEMBL30707,COUMESTROL
chembl:CHEMBL1096009,ALLOXAN
chembl:CHEMBL184,ACYCLOVIR
chembl:CHEMBL114,SAQUINAVIR
chembl:CHEMBL1179047,CHLOROPROCAINE
chembl:CHEMBL601353,CHEMBL601353
chembl:CHEMBL165,RESVERATROL
chembl:CHEMBL59150,CHEMBL59150
chembl:CHEMBL14830,ADENOSINE DIPHOSPHATE
chembl:CHEMBL817,TOLAZAMIDE
chembl:CHEMBL203135,BERBERRUBINE
chembl:CHEMBL1851943,PRACINOSTAT
GO:1901563,response to camptothecin
chembl:CHEMBL35337,AMFONELIC ACID
chembl:CHEMBL1514715,ETHAMSYLATE
chembl:CHEMBL4297886,ASUNERCEPT
chembl:CHEMBL2108038,MATUZUMAB
chembl:CHEMBL244888,NIFUROXAZIDE
chembl:CHEMBL1079421,PHENMEDIPHAM
chembl:CHEMBL281594,VANOXERINE
chembl:CHEMBL1201201,METHAMPHETAMINE
chembl:CHEMBL566534,ARTEMETHER
chembl:CHEMBL1201451,ALBUMIN HUMAN
chembl:CHEMBL484662,CHEMBL484662
chembl:CHEMBL462018,TRICIRIBINE PHOSPHATE
chembl:CHEMBL383634,GLIQUIDONE
chembl:CHEMBL249447,CHEMBL249447
chembl:CHEMBL4297866,ABIVERTINIB MALEATE
HP:0006934,Congenital nystagmus
chembl:CHEMBL14376,ILOPERIDONE
HP:0025711,Convergence-retraction nystagmus
HGNC:7527,MUTYH
chembl:CHEMBL1395447,NITROVIN
chembl:CHEMBL2017974,BUPARLISIB
chembl:CHEMBL1200596,CHLOROXINE
chembl:CHEMBL1334465,CHEMBL1334465
HP:0030903,Grasp reflex
chembl:CHEMBL288114,GALLIC ACID
chembl:CHEMBL496,HEXACHLOROPHENE
chembl:CHEMBL443684,NAVITOCLAX
chembl:CHEMBL23293,SALIRASIB
chembl:CHEMBL601605,CHEMBL601605
HP:0000657,Oculomotor apraxia
chembl:CHEMBL2105743,OLODATEROL HYDROCHLORIDE
HGNC:4332,BICRA
chembl:CHEMBL1697771,REBAMIPIDE
chembl:CHEMBL87223,AMINOQUINURIDE
chembl:CHEMBL1374360,MERCURIC CHLORIDE
MONDO:0005124,leprosy
chembl:CHEMBL499609,NAKIJIQUINONE I
chembl:CHEMBL589245,CHEMBL589245
chembl:CHEMBL1534525,MIBEFRADIL DIHYDROCHLORIDE
chembl:CHEMBL4298048,MP-0250
chembl:CHEMBL1201082,FLUOXETINE HYDROCHLORIDE
chembl:CHEMBL359744,DOXORUBICIN HYDROCHLORIDE
chembl:CHEMBL1354502,KOPARIN
chembl:CHEMBL803,CYTARABINE
chembl:CHEMBL112,ACETAMINOPHEN
chembl:CHEMBL1436980,"4,4'-DIMETHOXYDALBERGIONE"
chembl:CHEMBL155265,DNQX
chembl:CHEMBL196814,CHEMBL196814
chembl:CHEMBL2180604,TAK-593
chembl:CHEMBL463981,BEGACESTAT
MONDO:0001627,dementia
chembl:CHEMBL1200920,ISOETHARINE HYDROCHLORIDE
chembl:CHEMBL2364628,RICOLINOSTAT
chembl:CHEMBL3039530,ABEDITEROL
chembl:CHEMBL1762621,BARDOXOLONE METHYL
HGNC:613,APOE
MONDO:0016304,classic pantothenate kinase-associated neurodegeneration
MONDO:1010000,pythiosis
chembl:CHEMBL483254,PANOBINOSTAT
chembl:CHEMBL2218893,BEDORADRINE SULFATE
chembl:CHEMBL1586,BECLOMETHASONE
chembl:CHEMBL494083,XANTHOANGELOL
HGNC:427,ALK
HGNC:4812,HAP1
chembl:CHEMBL1201153,ISOETHARINE MESYLATE
chembl:CHEMBL1201728,DESVENLAFAXINE SUCCINATE
Reactome:R-CEL-390666,Serotonin receptors
CHEBI:50919,antiemetic
chembl:CHEMBL290914,EMODIC ACID
chembl:CHEMBL1201583,BEVACIZUMAB
HP:0001251,Ataxia
HGNC:90,ACADS
chembl:CHEMBL576349,IC261
HGNC:15864,RBCK1
chembl:CHEMBL3544962,CT-1578
chembl:CHEMBL270995,BRIVANIB ALANINATE
HP:0007221,Progressive truncal ataxia
chembl:CHEMBL3545252,DOCETAXEL
chembl:CHEMBL1201572,ETANERCEPT
chembl:CHEMBL2107826,VIBEGRON
chembl:CHEMBL1701915,CHEMBL1701915
chembl:CHEMBL4208229,ASCIMINIB
chembl:CHEMBL85685,CHRYSENE
MONDO:0015244,autosomal recessive cerebellar ataxia
chembl:CHEMBL1706,NAPHAZOLINE HYDROCHLORIDE
HGNC:93,ACAT1
chembl:CHEMBL1200322,ESCITALOPRAM OXALATE
chembl:CHEMBL347036,PROADIFEN HYDROCHLORIDE
HGNC:7461,MT-ND5
chembl:CHEMBL8946,ETICLOPRIDE
chembl:CHEMBL549473,DIPYRITHIONE
chembl:CHEMBL1743025,GANTENERUMAB
HGNC:129,ACTA1
chembl:CHEMBL578,ENALAPRIL
chembl:CHEMBL15192,LAPACHONE
chembl:CHEMBL119385,NEFLAMAPIMOD
chembl:CHEMBL531268,CHEMBL531268
chembl:CHEMBL493636,SULFANITRAN
Reactome:R-BTA-390651,Dopamine receptors
chembl:CHEMBL2012520,LY377604
chembl:CHEMBL462880,ISOBOLDINE
chembl:CHEMBL3545111,HEMAY-022
chembl:CHEMBL297304,CHEMBL297304
chembl:CHEMBL1464,WARFARIN
chembl:CHEMBL3187723,BINIMETINIB
chembl:CHEMBL267930,SPIPERONE
chembl:CHEMBL269732,TACROLIMUS
chembl:CHEMBL1405922,FENDILINE HYDROCHLORIDE
chembl:CHEMBL425,OLSALAZINE
chembl:CHEMBL4,OFLOXACIN
HP:0002470,Nonprogressive cerebellar ataxia
chembl:CHEMBL2364649,MARGETUXIMAB
chembl:CHEMBL13828,OXATOMIDE
chembl:CHEMBL1200694,SEVOFLURANE
chembl:CHEMBL3414621,TAZEMETOSTAT
chembl:CHEMBL3545248,DS-7423
chembl:CHEMBL1290,PENBUTOLOL
chembl:CHEMBL1743003,CONATUMUMAB
chembl:CHEMBL632,BETAMETHASONE
HP:0007811,Horizontal pendular nystagmus
GO:0030667,secretory granule membrane
MONDO:0030318,"spinocerebellar ataxia, autosomal recessive 30"
chembl:CHEMBL3544989,VOLANESORSEN SODIUM
chembl:CHEMBL322862,CHEMBL322862
chembl:CHEMBL1740,RACEPINEPHRINE
Reactome:R-DME-390651,Dopamine receptors
chembl:CHEMBL513000,EMETINE HYDROCHLORIDE
chembl:CHEMBL3137348,SENREBOTASE
HP:0001419,X-linked recessive inheritance
chembl:CHEMBL591628,CHEMBL591628
chembl:CHEMBL278315,GELDANAMYCIN
chembl:CHEMBL422,TRIFLUOPERAZINE
chembl:CHEMBL133576,ACID BLUE 129
chembl:CHEMBL47986,ERBSTATIN
chembl:CHEMBL465339,MUNDULONE
chembl:CHEMBL76688,SIVELESTAT
chembl:CHEMBL2103839,RIDAFOROLIMUS
chembl:CHEMBL1200493,NAFTIFINE HYDROCHLORIDE
HGNC:16695,BCAP31
MONDO:0018632,11q22.2q22.3 microdeletion syndrome
chembl:CHEMBL589694,CHEMBL589694
chembl:CHEMBL152231,AMOSULALOL
chembl:CHEMBL194400,HEPTACHLOR
chembl:CHEMBL461579,CHEMBL461579
chembl:CHEMBL578741,CHEMBL578741
chembl:CHEMBL1084546,PF-00562271
chembl:CHEMBL546,OXPRENOLOL
chembl:CHEMBL26138,CHEMBL26138
chembl:CHEMBL462576,KEPONE
chembl:CHEMBL375563,CHEMBL375563
chembl:CHEMBL413376,SURAMIN HEXASODIUM
Reactome:R-GGA-419469,Pyrimidine metabolism: de novo synthesis of UMP
chembl:CHEMBL820,BUSULFAN
chembl:CHEMBL2107358,OBATOCLAX MESYLATE
chembl:CHEMBL1642,IMATINIB MESYLATE
chembl:CHEMBL691,ETHINYL ESTRADIOL
HP:0000726,Dementia
chembl:CHEMBL422872,AZD-4769
HGNC:555,AP1G1
chembl:CHEMBL553,ERLOTINIB
HGNC:119,ACOX1
chembl:CHEMBL526,PROPOFOL
chembl:CHEMBL1946170,REGORAFENIB
chembl:CHEMBL421,SULFASALAZINE
chembl:CHEMBL582073,CHEMBL582073
MONDO:0011327,neuronal intranuclear inclusion disease
HGNC:11588,TBP
HGNC:251,ADH1C
chembl:CHEMBL372764,PERIFOSINE
HGNC:877,ALDH7A1
chembl:CHEMBL572878,TOZASERTIB
chembl:CHEMBL2036124,CHEMBL2036124
chembl:CHEMBL220241,GSK-269962A
chembl:CHEMBL1208858,CALMIDAZOLIUM CHLORIDE
HP:0009591,Abnormality of the vestibulocochlear nerve
chembl:CHEMBL171699,CHEMBL171699
chembl:CHEMBL578294,CHEMBL578294
chembl:CHEMBL1200379,APRACLONIDINE HYDROCHLORIDE
chembl:CHEMBL975,MESNA
chembl:CHEMBL1200494,GUANFACINE HYDROCHLORIDE
chembl:CHEMBL25,ASPIRIN
chembl:CHEMBL1200705,HYDROXYAMPHETAMINE HYDROBROMIDE
chembl:CHEMBL590686,CHEMBL590686
chembl:CHEMBL1520512,DEHYDROVARIABILIN
chembl:CHEMBL1005,REMIFENTANIL
chembl:CHEMBL2106195,DEXMEDETOMIDINE HYDROCHLORIDE
MONDO:0016564,progressive supranuclear palsy-progressive non-fluent aphasia syndrome
chembl:CHEMBL590,MENADIONE
chembl:CHEMBL582030,CHEMBL582030
chembl:CHEMBL52387,(RS)-ROSCOVITINE
chembl:CHEMBL2094789,CHEMBL2094789
chembl:CHEMBL3545360,ASP-3026
chembl:CHEMBL1873475,IBRUTINIB
chembl:CHEMBL24510,FUSARIC ACID
chembl:CHEMBL585656,CHEMBL585656
Reactome:R-MMU-390650,Histamine receptors
chembl:CHEMBL2333541,ARISTOYUNNOLIN A
Reactome:R-DME-390666,Serotonin receptors
chembl:CHEMBL790,CHLORHEXIDINE
MONDO:0007182,Machado-Joseph disease
MONDO:0014867,spinocerebellar ataxia 43
chembl:CHEMBL590186,CHEMBL590186
chembl:CHEMBL1255837,DIHYDROERGOCRISTINE MESYLATE
chembl:CHEMBL1402376,CHEMBL1402376
HGNC:29,ABCA1
chembl:CHEMBL1144,PRAVASTATIN
chembl:CHEMBL1742994,BRENTUXIMAB VEDOTIN
chembl:CHEMBL458094,CHEMBL458094
chembl:CHEMBL84567,TRACAZOLATE
MONDO:0008943,autosomal recessive spinocerebellar ataxia 2
chembl:CHEMBL1160544,TERBUTALINE SULFATE
CHEBI:77906,minocycline zwitterion
chembl:CHEMBL1200471,PYRITHIONE ZINC
HP:0011448,Ankle clonus
chembl:CHEMBL515252,CHEMBL515252
Reactome:R-BTA-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL2109300,GSK933776
HGNC:492,ANK1
chembl:CHEMBL3545163,AMP579
chembl:CHEMBL1398631,LAURYL ISOQUINOLINIUM
chembl:CHEMBL1441574,BENZO(K)FLUORANTHENE
chembl:CHEMBL417799,SANGUINARIUM
chembl:CHEMBL3990042,GOSURANEMAB
HGNC:177,ACY1
chembl:CHEMBL2095095,CHEMBL2095095
chembl:CHEMBL134342,THIOCTIC ACID
chembl:CHEMBL2110922,AMEZINIUM
HP:0012179,Craniofacial dystonia
chembl:CHEMBL3545313,BEMPEDOIC ACID
chembl:CHEMBL876,MECLOFENAMATE SODIUM
chembl:CHEMBL116438,CURCUMIN
chembl:CHEMBL321582,BUCINDOLOL
MONDO:0009567,Marinesco-Sjogren syndrome
chembl:CHEMBL1242196,DEHYDROMUTACTIN
chembl:CHEMBL4297397,QUERCETIN-3'-O-PHOSPHATE
chembl:CHEMBL515505,CHEMBL515505
chembl:CHEMBL508338,THIMEROSAL
chembl:CHEMBL131921,BIOCHANIN
chembl:CHEMBL2105325,RILOPIROX
chembl:CHEMBL592124,CHEMBL592124
chembl:CHEMBL600353,CHEMBL600353
chembl:CHEMBL2105732,LEVOMILNACIPRAN HYDROCHLORIDE
HGNC:53924,NOTCH2NLC
chembl:CHEMBL401844,CHEMBL401844
MONDO:0007661,Tourette syndrome
Reactome:R-BTA-211945,Phase I - Functionalization of compounds
MONDO:0014559,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome
chembl:CHEMBL1201581,INFLIXIMAB
chembl:CHEMBL1201295,BITOLTEROL
chembl:CHEMBL1467165,CHEMBL1467165
chembl:CHEMBL1256737,METHIOTHEPIN MESYLATE
MONDO:0006669,bacterial endocarditis
MONDO:0012321,Alzheimer disease 10
chembl:CHEMBL1200578,THEOPHYLLINE SODIUM GLYCINATE
chembl:CHEMBL3989767,CALCITONIN
chembl:CHEMBL449081,AGROCLAVINE
chembl:CHEMBL1200560,GUANABENZ ACETATE
chembl:CHEMBL1129,TRIFLURIDINE
chembl:CHEMBL539027,FLUNARIZINE DIHYDROCHLORIDE
Reactome:R-HSA-390651,Dopamine receptors
chembl:CHEMBL477772,PAZOPANIB
chembl:CHEMBL1526240,DIHYDROGAMBOGIC ACID
HGNC:2079,CLN8
HGNC:663,ARG1
HP:0002439,Frontolimbic dementia
chembl:CHEMBL329785,CHEMBL329785
chembl:CHEMBL429876,CILENGITIDE
chembl:CHEMBL832,SULFINPYRAZONE
MONDO:0012449,spinocerebellar ataxia type 23
chembl:CHEMBL2111110,TEDISAMIL
chembl:CHEMBL3545428,CHIAURANIB
chembl:CHEMBL268868,DAPH
MONDO:0005091,severe acute respiratory syndrome
HP:0006961,Jerky head movements
HGNC:7501,MT-TW
chembl:CHEMBL86754,IODOQUINOL
HGNC:637,AQP4
chembl:CHEMBL1200363,PENBUTOLOL SULFATE
chembl:CHEMBL70501,THUNBERGINOL B
CHEBI:36027,stilbenol
Reactome:R-DDI-611105,Respiratory electron transport
chembl:CHEMBL1230609,FORETINIB
HP:0002463,Language impairment
chembl:CHEMBL225519,CHEMBL225519
chembl:CHEMBL1306524,CHEMBL1306524
chembl:CHEMBL258867,EUPALININ A
HP:0011443,Abnormality of coordination
chembl:CHEMBL579318,CHEMBL579318
chembl:CHEMBL414890,PROTOAPIGENONE
chembl:CHEMBL1484,NICARDIPINE
chembl:CHEMBL483321,CP-724714
chembl:CHEMBL487,DROLOXIFENE
HGNC:170,ACTR3
chembl:CHEMBL24944,TRIBROMSALAN
chembl:CHEMBL76,CHLOROQUINE
chembl:CHEMBL1952329,SGI-1776
chembl:CHEMBL253989,CHEMBL253989
chembl:CHEMBL1201593,ALTEPLASE
MONDO:0005153,cervical adenocarcinoma
chembl:CHEMBL1256958,EPINEPHRINE BITARTRATE
chembl:CHEMBL2107832,PIMASERTIB
HP:0033203,Brachioradialis hyperreflexia
chembl:CHEMBL1607,TOPOTECAN HYDROCHLORIDE
chembl:CHEMBL1615374,VILAZODONE HYDROCHLORIDE
chembl:CHEMBL964,DISULFIRAM
chembl:CHEMBL1234354,PF-04691502
chembl:CHEMBL3639788,TELAGLENASTAT
chembl:CHEMBL3330650,RG-7420
chembl:CHEMBL41632,TIRATRICOL
chembl:CHEMBL1705,CLONIDINE HYDROCHLORIDE
MONDO:0011638,neuroferritinopathy
HP:0010543,Opsoclonus
chembl:CHEMBL1208903,ISOGINKGETIN
chembl:CHEMBL1436035,BISANHYDRORUTILANTINONE
chembl:CHEMBL4283683,DOMATINOSTAT
chembl:CHEMBL1477760,GRINIMIBINE
chembl:CHEMBL1339265,CYCLIRAMINE MALEATE
chembl:CHEMBL609628,CHEMBL609628
HGNC:391,AKT1
chembl:CHEMBL1256708,APOMORPHINE HYDROCHLORIDE HEMIHYDRATE
chembl:CHEMBL521851,PICTILISIB
chembl:CHEMBL582473,CHEMBL582473
chembl:CHEMBL1314,TIOPRONIN
chembl:CHEMBL1200413,TETRAHYDROZOLINE HYDROCHLORIDE
HP:0033205,Biceps hyperreflexia
chembl:CHEMBL1210769,CHEMBL1210769
chembl:CHEMBL459,METHYLDOPA
chembl:CHEMBL2364614,LIAFENSINE
chembl:CHEMBL4297774,JNJ-61186372
chembl:CHEMBL1490332,CHEMBL1490332
chembl:CHEMBL3545057,ACETYLDIGITOXIN
HP:0001252,Hypotonia
chembl:CHEMBL434,ISOPROTERENOL
chembl:CHEMBL429,LABETALOL
CHEBI:63726,neuroprotective agent
chembl:CHEMBL131,PREDNISOLONE
chembl:CHEMBL1797708,CHEMBL1797708
chembl:CHEMBL362558,LY-2090314
chembl:CHEMBL507361,PD-0325901
chembl:CHEMBL1215,PHENYLEPHRINE
chembl:CHEMBL141,LAMIVUDINE
chembl:CHEMBL3545320,ME-344
HGNC:291,ADSL
chembl:CHEMBL361497,ARTESUNATE
chembl:CHEMBL1256697,CHEMBL1256697
chembl:CHEMBL549208,CHEMBL549208
chembl:CHEMBL406845,CHEMBL406845
chembl:CHEMBL124660,TANDUTINIB
chembl:CHEMBL296586,KENPAULLONE
chembl:CHEMBL1498652,CHEMBL1498652
chembl:CHEMBL578063,ALAZANINE
chembl:CHEMBL1671,PROPRANOLOL HYDROCHLORIDE
chembl:CHEMBL160519,PROCATEROL
Reactome:R-BTA-500753,Pyrimidine biosynthesis
chembl:CHEMBL268368,STAUROSPORINE AGLYCON
chembl:CHEMBL1486690,PYRONIN Y
chembl:CHEMBL85,RISPERIDONE
chembl:CHEMBL31965,CANERTINIB
chembl:CHEMBL225071,RALTITREXED
chembl:CHEMBL3545424,AZD-8186
chembl:CHEMBL405355,NIGULDIPINE
chembl:CHEMBL546797,CHEMBL546797
chembl:CHEMBL463175,CEPHALOCHROMIN
chembl:CHEMBL888,GEMCITABINE
chembl:CHEMBL2107143,GLUFOSFAMIDE
chembl:CHEMBL28079,ZAPRINAST
chembl:CHEMBL193,NIFEDIPINE
chembl:CHEMBL430266,CALYCULIN A
chembl:CHEMBL559612,CP-55940
chembl:CHEMBL577419,CHEMBL577419
chembl:CHEMBL331372,CGS-21680
chembl:CHEMBL33845,DICHLOROPHEN
chembl:CHEMBL3686884,E-7090
chembl:CHEMBL22077,HYCANTHONE
chembl:CHEMBL163,RITONAVIR
chembl:CHEMBL1200947,METIPRANOLOL HYDROCHLORIDE
chembl:CHEMBL2088730,CHEMBL2088730
chembl:CHEMBL296468,BMS-387032
chembl:CHEMBL1200517,DIHYDROERGOTAMINE MESYLATE
chembl:CHEMBL553025,VINORELBINE
HP:0008026,Horizontal opticokinetic nystagmus
chembl:CHEMBL2105704,LENVATINIB MESYLATE
HGNC:469,AMPD2
chembl:CHEMBL3545413,FLUMATINIB
chembl:CHEMBL1200728,GUANIDINE HYDROCHLORIDE
chembl:CHEMBL1732,DIHYDROERGOTAMINE
chembl:CHEMBL258316,CHEMBL258316
chembl:CHEMBL363535,TANSHINONE I
chembl:CHEMBL1425,MERCAPTOPURINE
chembl:CHEMBL1312050,CHEMBL1312050
chembl:CHEMBL1200467,HYDROXYZINE PAMOATE
chembl:CHEMBL99408,CHEMBL99408
chembl:CHEMBL1683590,ERIBULIN
chembl:CHEMBL783,NATEGLINIDE
chembl:CHEMBL77387,CHEMBL77387
chembl:CHEMBL650,METHYLPREDNISOLONE
chembl:CHEMBL299853,CHEMBL299853
MONDO:0014688,short-rib thoracic dysplasia 14 with polydactyly
chembl:CHEMBL177126,CHEMBL177126
chembl:CHEMBL1221911,LACTIMIDOMYCIN
chembl:CHEMBL17331,PD-169316
chembl:CHEMBL601618,CHEMBL601618
chembl:CHEMBL1200964,AMITRIPTYLINE HYDROCHLORIDE
chembl:CHEMBL46286,OMACETAXINE MEPESUCCINATE
Reactome:R-CFA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL4297438,T-817 MALEATE
chembl:CHEMBL2109198,METHYLCELLULOSE
chembl:CHEMBL294264,PURPURIN
chembl:CHEMBL590927,CHEMBL590927
chembl:CHEMBL479,THIORIDAZINE
chembl:CHEMBL1200609,PAROXETINE MESYLATE
Reactome:R-GGA-611105,Respiratory electron transport
chembl:CHEMBL1795737,CHEMBL1795737
chembl:CHEMBL4298178,TRASTUZUMAB DUOCARMAZINE
chembl:CHEMBL1256660,CHEMBL1256660
chembl:CHEMBL170365,ACETALDEHYDE
MONDO:0100151,nephropathic cystinosis
chembl:CHEMBL578944,CHEMBL578944
HGNC:2347,CREB3
chembl:CHEMBL1743063,RILOTUMUMAB
chembl:CHEMBL549386,FOTEMUSTINE
HP:0001304,Torsion dystonia
chembl:CHEMBL55934,NAPHTHOQUINONE
chembl:CHEMBL197672,EMRICASAN
chembl:CHEMBL11417,STREPTONIGRIN
chembl:CHEMBL3989514,IRINOTECAN HYDROCHLORIDE
chembl:CHEMBL1713,CHLORPROMAZINE HYDROCHLORIDE
chembl:CHEMBL30432,GW282974X
chembl:CHEMBL376408,ABT 737
chembl:CHEMBL84010,CHEMBL84010
chembl:CHEMBL587723,AEE-788
chembl:CHEMBL477,ADENOSINE
chembl:CHEMBL1042,CHOLECALCIFEROL
chembl:CHEMBL120563,THIRAM
chembl:CHEMBL55400,PROFLAVINE
chembl:CHEMBL3621988,TUCIDINOSTAT
chembl:CHEMBL1801204,AZD-8055
chembl:CHEMBL2333547,ARISTOLACTONE
chembl:CHEMBL536151,CHEMBL536151
chembl:CHEMBL501680,BILIRUBIN
chembl:CHEMBL1449651,"PYRROLIDINE DITHIOCARBAMIC ACID, AMMONIUM SALT"
chembl:CHEMBL357995,BOPINDOLOL
chembl:CHEMBL375611,LY404039
chembl:CHEMBL286494,HYPERICIN
chembl:CHEMBL3545297,PEXMETINIB
MONDO:0021136,rare
chembl:CHEMBL2109393,RG-7160
chembl:CHEMBL185,FLUOROURACIL
chembl:CHEMBL1576310,CHEMBL1576310
HP:0034674,Abnormal ankle physiology
chembl:CHEMBL548615,CHEMBL548615
chembl:CHEMBL1317986,CHEMBL1317986
chembl:CHEMBL2005186,CHEMBL2005186
CHEBI:46920,N-methylpiperazine
chembl:CHEMBL191083,METHYLENE BLUE
chembl:CHEMBL777,CLAVULANIC ACID
CHEBI:26195,polyphenol
chembl:CHEMBL2109355,DUSIGITUMAB
chembl:CHEMBL1304363,CHEMBL1304363
chembl:CHEMBL12,DIAZEPAM
chembl:CHEMBL2333550,MADOLIN T
chembl:CHEMBL2109388,FUTUXIMAB
chembl:CHEMBL1201454,ALSEROXYLON
chembl:CHEMBL294018,PATULIN
HP:0009878,Cerebellar ataxia associated with quadrupedal gait
HGNC:8101,OCA2
chembl:CHEMBL1200405,BITOLTEROL MESYLATE
chembl:CHEMBL65,CAMPTOTHECIN
chembl:CHEMBL257158,CHEMBL257158
HGNC:483,ANG
chembl:CHEMBL1201177,LEVOBUNOLOL HYDROCHLORIDE
HP:0002395,Lower limb hyperreflexia
chembl:CHEMBL136689,CHEMBL136689
chembl:CHEMBL2177349,HALICLONADIAMINE
chembl:CHEMBL2108628,PACLITAXEL POLIGLUMEX
chembl:CHEMBL290916,EDARAVONE
chembl:CHEMBL580071,CHEMBL580071
chembl:CHEMBL1089641,TRYPAN BLUE
chembl:CHEMBL587849,CHEMBL587849
chembl:CHEMBL476,DACARBAZINE
chembl:CHEMBL31184,BENZO[DEF]CHRYSENE
chembl:CHEMBL11359,CISPLATIN
chembl:CHEMBL83063,RITODRINE
HP:0031008,Lingual dystonia
chembl:CHEMBL128,SUMATRIPTAN
HGNC:6893,MAPT
chembl:CHEMBL3039513,DECERNOTINIB
chembl:CHEMBL585628,CHEMBL585628
chembl:CHEMBL3544935,XL-418
wikidata:Q47522319,XELJANZ
HGNC:438,ALPL
chembl:CHEMBL2109662,DALANTERCEPT
chembl:CHEMBL220998,"FUCHSIN, BASIC"
chembl:CHEMBL4298025,ZENOCUTUZUMAB
CHEBI:27656,camptothecin
chembl:CHEMBL3622533,FIMEPINOSTAT
chembl:CHEMBL324842,ROSMARINIC ACID
chembl:CHEMBL254219,DIGITOXIN
chembl:CHEMBL465843,PIPLARTINE
chembl:CHEMBL2108359,NIMOTUZUMAB
chembl:CHEMBL1370561,AMINOPHYLLINE
chembl:CHEMBL580155,CHEMBL580155
MONDO:0014179,inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 3
chembl:CHEMBL1852688,INFIGRATINIB
chembl:CHEMBL1374986,BISSALICYL FUMARATE
chembl:CHEMBL581225,CHEMBL581225
chembl:CHEMBL2108989,ASPARAGINASE
chembl:CHEMBL314639,CHEMBL314639
chembl:CHEMBL1183717,ALMITRINE
Reactome:R-DME-500753,Pyrimidine biosynthesis
chembl:CHEMBL601110,CHEMBL601110
chembl:CHEMBL291143,CHEMBL291143
chembl:CHEMBL361812,RAMATROBAN
chembl:CHEMBL1098,BUPIVACAINE
chembl:CHEMBL2105712,AFATINIB DIMALEATE
chembl:CHEMBL514057,GERONTOXANTHONE H
HP:0000725,Psychotic episodes
Reactome:R-SSC-211945,Phase I - Functionalization of compounds
chembl:CHEMBL14563,SB-242084
chembl:CHEMBL316040,TEPOXALIN
chembl:CHEMBL509032,TAE-684
chembl:CHEMBL1200883,THONZONIUM BROMIDE
chembl:CHEMBL1823787,CHEMBL1823787
chembl:CHEMBL104,CLOTRIMAZOLE
chembl:CHEMBL188762,CHEMBL188762
chembl:CHEMBL497,CLIOQUINOL
chembl:CHEMBL90555,VINCRISTINE
MONDO:0012246,spinocerebellar ataxia type 26
HGNC:31326,ATXN2L
chembl:CHEMBL65717,MEPINDOLOL
chembl:CHEMBL575448,BMS-754807
chembl:CHEMBL591137,CHEMBL591137
chembl:CHEMBL393136,POMIFERIN
chembl:CHEMBL36,PYRIMETHAMINE
chembl:CHEMBL322970,CHEMBL322970
wikidata:Q29006033,IRESSA
chembl:CHEMBL538104,CHEMBL538104
chembl:CHEMBL1308,FOMEPIZOLE
chembl:CHEMBL477841,CHEMBL477841
chembl:CHEMBL1201585,TRASTUZUMAB
chembl:CHEMBL270299,BAY-11-7085
chembl:CHEMBL1190,DECAMETHONIUM
chembl:CHEMBL601933,CHEMBL601933
chembl:CHEMBL2109384,DEMCIZUMAB
chembl:CHEMBL223360,LINIFANIB
chembl:CHEMBL1200748,CARBIDOPA
chembl:CHEMBL602946,CHEMBL602946
chembl:CHEMBL1200328,DULOXETINE HYDROCHLORIDE
HGNC:8851,PEX10
chembl:CHEMBL34259,METHOTREXATE
MONDO:0010983,dystonia 9
chembl:CHEMBL1200873,PHENTOLAMINE MESYLATE
chembl:CHEMBL538965,CHEMBL538965
chembl:CHEMBL433680,ANGUIDIN
HGNC:26775,TMEM192
chembl:CHEMBL2107773,RITOBEGRON
chembl:CHEMBL2103851,AMUVATINIB
chembl:CHEMBL2002849,CHEMBL2002849
HP:0100022,Abnormality of movement
chembl:CHEMBL844,BRIMONIDINE
chembl:CHEMBL495873,MAHANIMBINE
chembl:CHEMBL111,RIMONABANT
MONDO:0043544,nosocomial infection
chembl:CHEMBL12856,INAMRINONE
chembl:CHEMBL1224785,MADOLIN A
chembl:CHEMBL3545002,MP-412
MONDO:0005355,coronary restenosis
chembl:CHEMBL343002,CHEMBL343002
chembl:CHEMBL2408045,SAPITINIB
chembl:CHEMBL1201167,CARVEDILOL PHOSPHATE
chembl:CHEMBL525826,CHEMBL525826
chembl:CHEMBL122701,CHEMBL122701
chembl:CHEMBL266481,GLUCAGON
wikidata:Q6460439,GATAPARSEN
chembl:CHEMBL450449,TRABECTEDIN
HP:0007747,Monocular horizontal nystagmus
HGNC:9701,PURA
MONDO:0016681,gliosarcoma
chembl:CHEMBL1289601,LENVATINIB
chembl:CHEMBL1508,ESCITALOPRAM
chembl:CHEMBL1983268,ENTRECTINIB
chembl:CHEMBL50894,ALSTERPAULLONE
chembl:CHEMBL2108058,VANUTIDE CRIDIFICAR
MONDO:0033480,spinocerebellar ataxia 45
chembl:CHEMBL1200874,"TOLBUTAMIDE SODIUM, STERILE"
chembl:CHEMBL3545281,AKN-028
wikidata:Q58526200,HUMAN GROWTH HORMONE
chembl:CHEMBL490355,SULFURETIN
chembl:CHEMBL15137,MICHLER'S KETONE
chembl:CHEMBL1329029,TETROQUINONE
chembl:CHEMBL189963,PALBOCICLIB
MONDO:0019260,adult neuronal ceroid lipofuscinosis
chembl:CHEMBL1490495,MECYSTEINE HYDROCHLORIDE
chembl:CHEMBL31574,FISETIN
chembl:CHEMBL608533,MIDOSTAURIN
chembl:CHEMBL530115,GUTHION
HP:0007240,Progressive gait ataxia
HP:0002066,Gait ataxia
chembl:CHEMBL6206,BROMOENOL LACTONE
HGNC:25321,SHARPIN
chembl:CHEMBL1489,AZACITIDINE
chembl:CHEMBL228281,NORSTICTIC ACID
chembl:CHEMBL189584,PD-173074
HGNC:6180,ITPR1
chembl:CHEMBL502496,CHEMBL502496
chembl:CHEMBL1922094,APITOLISIB
chembl:CHEMBL3707381,OFRANERGENE OBADENOVEC
chembl:CHEMBL223575,CHEMBL223575
chembl:CHEMBL1565322,NIHYDRAZONE
chembl:CHEMBL3545376,ERDAFITINIB
chembl:CHEMBL4297489,CXD-101
MONDO:0007739,Huntington disease
chembl:CHEMBL1201334,TRIPTORELIN
chembl:CHEMBL374632,CHEMBL374632
chembl:CHEMBL289277,EMODIN
HP:5200045,Reduced impulse control
chembl:CHEMBL4297556,MM-111
chembl:CHEMBL2386881,CAPROSPINOL
chembl:CHEMBL1902074,CHEMBL1902074
chembl:CHEMBL80155,CHEMBL80155
CHEBI:87113,antibiotic antifungal drug
chembl:CHEMBL46516,FLUSPIRILENE
chembl:CHEMBL288441,BOSUTINIB
chembl:CHEMBL173929,LUTEIN
chembl:CHEMBL82970,SALICYLANILIDE
chembl:CHEMBL487253,BENDAMUSTINE
MONDO:0005401,colonic neoplasm
chembl:CHEMBL328710,CHEMBL328710
MONDO:0009319,pantothenate kinase-associated neurodegeneration
HGNC:14203,JPH3
chembl:CHEMBL405130,WHI-P131
HP:0000736,Short attention span
chembl:CHEMBL175266,CHEMBL175266
chembl:CHEMBL1496,ROSUVASTATIN
chembl:CHEMBL1519374,CHEMBL1519374
chembl:CHEMBL449214,GRACILIN A
MONDO:0008083,"ceroid lipofuscinosis, neuronal, 4 (Kufs type)"
chembl:CHEMBL1213492,GIVINOSTAT
chembl:CHEMBL10,SB-203580
chembl:CHEMBL42,CLOZAPINE
chembl:CHEMBL2007641,PERTUZUMAB
HGNC:6239,KCND3
chembl:CHEMBL1814509,CHEMBL1814509
MONDO:0004979,asthma
HP:0025153,Transient
HGNC:9118,PMP22
chembl:CHEMBL1256910,TREQUINSIN HYDROCHLORIDE
HGNC:7467,MTTP
chembl:CHEMBL160,CYCLOSPORINE
chembl:CHEMBL1072,BUMETANIDE
chembl:CHEMBL1089636,ANG1005
HP:0001315,Reduced tendon reflexes
HGNC:795,ATM
chembl:CHEMBL1401,NITAZOXANIDE
chembl:CHEMBL1908397,KW-2449
chembl:CHEMBL494255,AROMATICIN
chembl:CHEMBL1625,OXYBENZONE
chembl:CHEMBL3545311,BRIGATINIB
chembl:CHEMBL416288,(S)APOMORPHINE
MONDO:0008119,spinocerebellar ataxia type 1
chembl:CHEMBL67,COMBRETASTATIN A4
chembl:CHEMBL172064,E324
chembl:CHEMBL307346,CETRIMONIUM BROMIDE
chembl:CHEMBL2087361,ICOTINIB
chembl:CHEMBL579105,CHEMBL579105
chembl:CHEMBL45816,MIBEFRADIL
chembl:CHEMBL1351,CARBOPLATIN
chembl:CHEMBL1242194,CYCLOSTREPTIN
chembl:CHEMBL59990,MAFOSFAMIDE
HGNC:4398,GNB2
chembl:CHEMBL1258517,PKI-179
HP:0001265,Hyporeflexia
chembl:CHEMBL3545358,4SC-203
HGNC:7225,MPZ
chembl:CHEMBL480,LANSOPRAZOLE
chembl:CHEMBL580421,CHEMBL580421
chembl:CHEMBL1229517,VEMURAFENIB
chembl:CHEMBL1201827,PANITUMUMAB
chembl:CHEMBL1076184,CIMIRACEMATE A
chembl:CHEMBL309339,SALICYLHYDROXAMIC ACID
chembl:CHEMBL447664,VIPADENANT
chembl:CHEMBL29898,QUINALIZARIN
chembl:CHEMBL3545180,THELIATINIB
chembl:CHEMBL585591,CHEMBL585591
HP:0002380,Fasciculations
HGNC:395,ALAD
MONDO:0019794,autosomal dominant cerebellar ataxia type IV
chembl:CHEMBL17860,LOFEXIDINE
chembl:CHEMBL1822792,MK-2461
chembl:CHEMBL2062257,BRIMONIDINE TARTRATE
chembl:CHEMBL6966,VERAPAMIL
chembl:CHEMBL837,7-ETHYL-10-HYDROXYCAMPTOTHECIN
chembl:CHEMBL495727,AT-9283
chembl:CHEMBL1743024,GANITUMAB
chembl:CHEMBL1479103,HAEMATOXYLIN
chembl:CHEMBL1743082,TRASTUZUMAB EMTANSINE
HGNC:4922,HK1
wikidata:Q798309,BCG VACCINE
HP:0006803,Vivid hallucinations
chembl:CHEMBL1528359,CHEMBL1528359
chembl:CHEMBL190083,TARENFLURBIL
chembl:CHEMBL284328,HOMIDIUM BROMIDE
chembl:CHEMBL587620,CHEMBL587620
chembl:CHEMBL554054,APTIGANEL HYDROCHLORIDE
chembl:CHEMBL684,DIETHYLCARBAMAZINE
chembl:CHEMBL451197,OXIDOPAMINE HYDROCHLORIDE
chembl:CHEMBL421215,CHEMBL421215
chembl:CHEMBL1526167,CHEMBL1526167
chembl:CHEMBL541230,CHEMBL541230
chembl:CHEMBL21241,GW7647
chembl:CHEMBL578257,CHEMBL578257
chembl:CHEMBL1879463,DACTOLISIB
chembl:CHEMBL3545402,XL-820
HGNC:4177,GBA1
MONDO:0100053,anaphylaxis
chembl:CHEMBL6291,BISINDOLYLMALEIMIDE IX
chembl:CHEMBL1291,METIPRANOLOL
chembl:CHEMBL446315,ERGOCRISTINE
chembl:CHEMBL90593,PRASTERONE
chembl:CHEMBL210618,CHEMBL210618
MONDO:0023076,eosinophilic pustular folliculitis
chembl:CHEMBL1944698,ZOTIRACICLIB
chembl:CHEMBL1980715,LAUROGUADINE
chembl:CHEMBL845,N-DESMETHYLCLOZAPINE
chembl:CHEMBL529939,CHEMBL529939
chembl:CHEMBL240624,PRELADENANT
chembl:CHEMBL219557,CHEMBL219557
chembl:CHEMBL4297184,CIFORADENANT
chembl:CHEMBL3545270,LY2969822
chembl:CHEMBL486231,CHEMBL486231
chembl:CHEMBL2105717,CABOZANTINIB
chembl:CHEMBL865,VALDECOXIB
CHEBI:24373,glycine derivative
chembl:CHEMBL472212,CHEMBL472212
chembl:CHEMBL18,ETHOXZOLAMIDE
HP:0006979,Sleep-wake cycle disturbance
chembl:CHEMBL528712,CHEMBL528712
chembl:CHEMBL628,PENTOXIFYLLINE
chembl:CHEMBL1193948,AMIBEGRON
chembl:CHEMBL326967,CHLOROETHYLCLONIDINE
chembl:CHEMBL1563,DAUNORUBICIN HYDROCHLORIDE
chembl:CHEMBL206452,CATECHIN
chembl:CHEMBL173530,STICTIC ACID
chembl:CHEMBL1320453,CHEMBL1320453
chembl:CHEMBL852,MELPHALAN
HP:0002136,Broad-based gait
chembl:CHEMBL7939,CGP-53353
chembl:CHEMBL421701,DITHIAZANINE IODIDE
chembl:CHEMBL244743,ESCULETIN
chembl:CHEMBL531401,CHEMBL531401
chembl:CHEMBL1530911,CHEMBL1530911
HP:0007738,Uncontrolled eye movements
chembl:CHEMBL64894,GENTIAN VIOLET
chembl:CHEMBL591404,CHEMBL591404
chembl:CHEMBL1670,MITOTANE
chembl:CHEMBL729,LOPINAVIR
MONDO:0007488,Lewy body dementia
HGNC:9187,POLR2A
UPHENO:0080275,decreased motor coordination
chembl:CHEMBL1219,RABEPRAZOLE
chembl:CHEMBL2010872,CEP-11981
chembl:CHEMBL261237,CHEMBL261237
chembl:CHEMBL601192,CHEMBL601192
MONDO:0030805,spinocerebellar ataxia 49
HP:0011728,Elbow clonus
chembl:CHEMBL222645,FLOXACILLIN
chembl:CHEMBL556,DEFEROXAMINE
chembl:CHEMBL1200952,METHAMPHETAMINE HYDROCHLORIDE
chembl:CHEMBL3039597,GENTAMICIN
chembl:CHEMBL4297816,PX-478
chembl:CHEMBL599924,CHEMBL599924
chembl:CHEMBL3707294,DEPATUXIZUMAB
chembl:CHEMBL64239,CHEMBL64239
chembl:CHEMBL1510164,CHEMBL1510164
chembl:CHEMBL3989972,BALIPODECT
chembl:CHEMBL1095097,EPLERENONE
chembl:CHEMBL40,PHENOBARBITAL
chembl:CHEMBL111201,CHEMBL111201
chembl:CHEMBL1481974,CHEMBL1481974
chembl:CHEMBL3935857,SERABELISIB
chembl:CHEMBL116548,CHEMBL116548
HGNC:8874,PFKFB3
HP:0007350,Hyperreflexia in upper limbs
chembl:CHEMBL206468,AFEGOSTAT
chembl:CHEMBL92,DOCETAXEL
chembl:CHEMBL15770,SULINDAC
MONDO:0004150,breast giant fibroadenoma
chembl:CHEMBL481,IRINOTECAN
chembl:CHEMBL2177390,IPATASERTIB
HP:0033204,Triceps hyperreflexia
chembl:CHEMBL444109,GAMBOGIC AMIDE
chembl:CHEMBL1201179,LAPATINIB DITOSYLATE
chembl:CHEMBL482050,CHEMBL482050
chembl:CHEMBL403741,CHEMBL403741
chembl:CHEMBL176045,FANCHININ
chembl:CHEMBL16264,ETHER
MONDO:0012103,spinocerebellar ataxia type 25
chembl:CHEMBL1094636,NIRAPARIB
chembl:CHEMBL1077108,FUROSPONGOLIDE
chembl:CHEMBL52606,COLFORSIN
chembl:CHEMBL92129,CRYPTOLEPINE HYDROCHLORIDE
chembl:CHEMBL646,TRIAZOLAM
CHEBI:27881,resveratrol
chembl:CHEMBL9514,NOCODAZOLE
HP:0011449,Knee clonus
CHEBI:66924,creatinate
HGNC:758,ASS1
chembl:CHEMBL1980391,RG-1530
HGNC:57,ABCC6
chembl:CHEMBL606167,CHEMBL606167
chembl:CHEMBL284028,"2,3-DIHYDROXY-6,7-DICHLOROQUINOXALINE"
chembl:CHEMBL1090090,VX-702
chembl:CHEMBL2325741,CAPIVASERTIB
HP:0007083,Hyperactive patellar reflex
chembl:CHEMBL1328898,MELEVODOPA
chembl:CHEMBL1088751,PH-797804
chembl:CHEMBL551842,LOBARIC ACID
HP:0002457,Abnormal head movements
HP:0012043,Pendular nystagmus
MONDO:0044332,childhood-onset benign chorea with striatal involvement
chembl:CHEMBL718,METHYLDOPA (RACEMIC)
MONDO:0032673,"basal ganglia calcification, idiopathic, 7, autosomal recessive"
Reactome:R-GGA-390651,Dopamine receptors
chembl:CHEMBL3545110,RIBOCICLIB
chembl:CHEMBL1427,HYPOXANTHINE
HP:0020036,Upper limb dysmetria
chembl:CHEMBL1077759,GRACILIN J
HP:0012547,Abnormal involuntary eye movements
chembl:CHEMBL1409,FLUVOXAMINE MALEATE
chembl:CHEMBL486696,DOMIPHEN BROMIDE
chembl:CHEMBL2333548,CHEMBL2333548
HGNC:33882,INPP5K
chembl:CHEMBL1454910,NITROXOLINE
chembl:CHEMBL278041,SB-202190
MONDO:0000167,Huntington disease and related disorders
Reactome:R-RNO-211945,Phase I - Functionalization of compounds
chembl:CHEMBL1287983,CHEMBL1287983
chembl:CHEMBL1589,ACETOHEXAMIDE
chembl:CHEMBL1773,CAPECITABINE
chembl:CHEMBL4297312,ORM-12741
chembl:CHEMBL459769,TASOCITINIB
HP:0002119,Ventriculomegaly
chembl:CHEMBL2364626,RALIMETINIB
chembl:CHEMBL28626,MORIN
chembl:CHEMBL36148,(S)-VERAPAMIL
HGNC:5961,IKBKG
chembl:CHEMBL2219422,AFURESERTIB
chembl:CHEMBL1237054,PLICAMYCIN
chembl:CHEMBL1205,NELFINAVIR MESYLATE
chembl:CHEMBL1976040,ADAVOSERTIB
chembl:CHEMBL323197,MANGOSTIN
chembl:CHEMBL530291,CHEMBL530291
chembl:CHEMBL1950649,APADENOSON
chembl:CHEMBL3545063,OSIMERTINIB MESYLATE
chembl:CHEMBL3545026,FAMITINIB
HP:0031466,Impairment in personality functioning
chembl:CHEMBL1256752,FLUPIRTINE MALEATE
HP:0001348,Brisk reflexes
chembl:CHEMBL1434513,NOREPINEPHRINE BITARTRATE
chembl:CHEMBL1867091,RIMSULFURON
chembl:CHEMBL56543,CHEMBL56543
chembl:CHEMBL1333653,OBTUSAQUINONE
chembl:CHEMBL1423,PIMOZIDE
chembl:CHEMBL333826,DEQUALINIUM
chembl:CHEMBL2094833,CHEMBL2094833
MONDO:0011819,spinocerebellar ataxia type 19/22
chembl:CHEMBL1201752,IXABEPILONE
chembl:CHEMBL1599768,PYRANTEL PAMOATE
chembl:CHEMBL3545103,AZD3199
chembl:CHEMBL1513686,12A-HYDROXY-5-DEOXYDEHYDROMUNDUSERONE
chembl:CHEMBL210868,AURIN
chembl:CHEMBL253969,OSI-632
chembl:CHEMBL3545133,JNJ-26483327
chembl:CHEMBL809,SERTRALINE
chembl:CHEMBL312163,RHAMNETIN
chembl:CHEMBL1951071,ARFORMOTEROL TARTRATE
chembl:CHEMBL15245,YOHIMBINE
chembl:CHEMBL168276,"3,5-DINITROCATECHOL (OR-486)"
chembl:CHEMBL19224,PAPAVERINE
HP:0007704,Paroxysmal involuntary eye movements
chembl:CHEMBL1160008,IODOPHTHALEIN
MONDO:0011671,Huntington disease-like 2
chembl:CHEMBL581872,CHEMBL581872
chembl:CHEMBL3545409,BVT.115959
chembl:CHEMBL2105708,PONATINIB HYDROCHLORIDE
chembl:CHEMBL2181041,CHEMBL2181041
chembl:CHEMBL1256783,CHEMBL1256783
chembl:CHEMBL1082607,SALMETEROL XINAFOATE
HP:0002186,Apraxia
chembl:CHEMBL1201002,CARTEOLOL HYDROCHLORIDE
chembl:CHEMBL1322879,"2,3,4-TRIHYDROXY-4'-ETHOXYBENZOPHENONE"
chembl:CHEMBL2105643,FOSBRETABULIN TROMETHAMINE
chembl:CHEMBL1201821,PALIFERMIN
chembl:CHEMBL1094785,CARMOTEROL
chembl:CHEMBL1371413,"2,3-DIHYDROXY-4-METHOXY-4'-ETHOXYBENZOPHENONE"
chembl:CHEMBL1590,PSEUDOEPHEDRINE
chembl:CHEMBL579837,CHEMBL579837
chembl:CHEMBL61,PODOFILOX
chembl:CHEMBL550011,CHLORPYRAMIN HYDROCHLORIDE
chembl:CHEMBL254218,DESMETHOXYYANGONIN
HGNC:3771,FMO3
chembl:CHEMBL1200569,"CAFFEINE, CITRATED"
chembl:CHEMBL431701,SILYBIN A
chembl:CHEMBL77921,MEDETOMIDINE
chembl:CHEMBL598797,CUDC-101
HGNC:118,ACO2
chembl:CHEMBL1405,ESTRONE
chembl:CHEMBL127592,OXETHAZAINE
chembl:CHEMBL129177,HARMALOL
chembl:CHEMBL508649,5-METHOXYCANTHINONE
chembl:CHEMBL530361,CHEMBL530361
chembl:CHEMBL1230065,BMS-582949
chembl:CHEMBL4298018,LY-3164530
Reactome:R-GGA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL1201556,BECAPLERMIN
chembl:CHEMBL56393,CHEMBL56393
chembl:CHEMBL244707,CHEMBL244707
chembl:CHEMBL998,LORATADINE
chembl:CHEMBL32800,FENOTEROL
chembl:CHEMBL3545051,CEP-37440
chembl:CHEMBL2107779,SEMAPIMOD
chembl:CHEMBL1336,SORAFENIB
chembl:CHEMBL483158,ALISERTIB
chembl:CHEMBL41,FLUOXETINE
chembl:CHEMBL579957,CHEMBL579957
chembl:CHEMBL710,FINASTERIDE
chembl:CHEMBL254760,MGCD-265
chembl:CHEMBL607707,PELITINIB
chembl:CHEMBL3545382,R-348
CHEBI:33572,resorcinols
Reactome:R-HSA-390666,Serotonin receptors
chembl:CHEMBL8739,LINOLENIC ACID
chembl:CHEMBL38,TRETINOIN
chembl:CHEMBL126804,CHEMBL126804
chembl:CHEMBL1008,BEPRIDIL
chembl:CHEMBL1201288,DANTROLENE
chembl:CHEMBL2178577,AZD-5363
chembl:CHEMBL572881,MOTESANIB
chembl:CHEMBL528181,CHEMBL528181
chembl:CHEMBL312448,XYLOMETAZOLINE
chembl:CHEMBL36506,NOVOBIOCIN
chembl:CHEMBL604311,CHEMBL604311
MONDO:0016563,progressive supranuclear palsy-corticobasal syndrome
chembl:CHEMBL1789844,IPILIMUMAB
chembl:CHEMBL468154,SCYLLITOL
Reactome:R-HSA-500753,Pyrimidine biosynthesis
chembl:CHEMBL602969,CHEMBL602969
MONDO:0008458,spinocerebellar ataxia type 2
chembl:CHEMBL310934,CHEMBL310934
chembl:CHEMBL186141,ANDROGRAPHOLIDE
chembl:CHEMBL579725,CHEMBL579725
chembl:CHEMBL539947,TYRPHOSTIN AG 879
chembl:CHEMBL548017,CHEMBL548017
chembl:CHEMBL474260,CARUBICIN
chembl:CHEMBL88272,CHEMBL88272
chembl:CHEMBL275938,AURINTRICARBOXYLIC ACID
chembl:CHEMBL580183,CHEMBL580183
chembl:CHEMBL1201580,ADALIMUMAB
MONDO:0005116,Whipple disease
chembl:CHEMBL564,PROMAZINE
HP:0002522,Areflexia of lower limbs
chembl:CHEMBL1487183,ALEXIDINE HYDROCHLORIDE
HGNC:8820,PDYN
chembl:CHEMBL1099167,CHEMBL1099167
HGNC:756,ASPA
MONDO:0002050,depressive disorder
chembl:CHEMBL602718,CHEMBL602718
chembl:CHEMBL1760,TERBUTALINE
chembl:CHEMBL258893,CHELERYTHRINE CHLORIDE
HGNC:10990,SLC25A4
chembl:CHEMBL2103860,USISTAPIDE
chembl:CHEMBL1200332,PROTRIPTYLINE HYDROCHLORIDE
wikidata:Q47521502,DOXIL
chembl:CHEMBL1436860,DIMETHYL GAMBOGATE
MONDO:0002679,cerebral infarction
chembl:CHEMBL586000,CHEMBL586000
HGNC:799,ATP1A1
chembl:CHEMBL607253,CHEMBL607253
chembl:CHEMBL609606,CHEMBL609606
UPHENO:0055092,increased reflex
chembl:CHEMBL18028,5-OXO-ETE
MONDO:0019262,juvenile neuronal ceroid lipofuscinosis
HP:0001337,Tremor
chembl:CHEMBL378544,VINBLASTINE SULFATE
chembl:CHEMBL1024,IFOSFAMIDE
HGNC:12811,XK
chembl:CHEMBL1743018,FICLATUZUMAB
chembl:CHEMBL267548,PROTOPORPHYRIN
chembl:CHEMBL187460,CRYPTOTANSHINONE
chembl:CHEMBL4297851,XMT-1536
chembl:CHEMBL409450,6BIO
chembl:CHEMBL459324,DIACETYLMORPHINE
chembl:CHEMBL1240967,PF-00610355
chembl:CHEMBL1430,PENICILLAMINE
chembl:CHEMBL1513,IRBESARTAN
chembl:CHEMBL1357517,DEXEFAROXAN
chembl:CHEMBL2181040,CHEMBL2181040
chembl:CHEMBL100473,U-0126
chembl:CHEMBL180682,AMMONIUM TRICHLOROTELLURATE
HP:0007123,Subcortical dementia
MONDO:0005359,drug-induced liver injury
chembl:CHEMBL494089,GSK-690693
chembl:CHEMBL14249,ADENOSINE TRIPHOSPHATE
chembl:CHEMBL18132,SR-2640
chembl:CHEMBL1485809,CHEMBL1485809
chembl:CHEMBL3545003,MSC-2363318A
MONDO:0003646,rectum neuroendocrine neoplasm
chembl:CHEMBL1743058,PONEZUMAB
chembl:CHEMBL654,MIRTAZAPINE
chembl:CHEMBL4298094,ARCHEXIN
chembl:CHEMBL239439,CHEMBL239439
chembl:CHEMBL267099,TUBERCIDIN
chembl:CHEMBL2220442,FLUVASTATIN
chembl:CHEMBL51,KETANSERIN
chembl:CHEMBL492399,VERUBULIN
chembl:CHEMBL2110563,CYANOCOBALAMIN
chembl:CHEMBL597035,CHEMBL597035
chembl:CHEMBL2107762,NERISPIRDINE
chembl:CHEMBL108,CARBAMAZEPINE
chembl:CHEMBL258805,SU-9516
chembl:CHEMBL276711,SEMAXANIB
chembl:CHEMBL4297188,MIRANSERTIB
chembl:CHEMBL1266,TETRAHYDROZOLINE
HP:0006863,Severe expressive language delay
chembl:CHEMBL2338397,CRENIGACESTAT
wikidata:Q27285013,DEBIO-1347
chembl:CHEMBL1911631,YUANHUADINE
chembl:CHEMBL625,THIABENDAZOLE
chembl:CHEMBL1407943,CLEMIZOLE
chembl:CHEMBL2095212,MIRABEGRON
chembl:CHEMBL403183,CHEMBL403183
chembl:CHEMBL1068,OXCARBAZEPINE
HP:0100851,Abnormal emotion/affect behavior
chembl:CHEMBL46917,CARBARIL
MONDO:0002601,teratoma
chembl:CHEMBL532849,CHEMBL532849
chembl:CHEMBL1683544,ERIBULIN MESYLATE
chembl:CHEMBL1908360,EVEROLIMUS
chembl:CHEMBL1201565,EPOETIN ALFA
chembl:CHEMBL350221,OXITRIPTAN
chembl:CHEMBL1201485,SOYBEAN OIL
chembl:CHEMBL1967878,CENISERTIB
chembl:CHEMBL104255,FLAVOKAWAIN B
chembl:CHEMBL985,UREA
chembl:CHEMBL408500,CHEMBL408500
chembl:CHEMBL4297782,MINNELIDE
chembl:CHEMBL2107457,ITOPRIDE
chembl:CHEMBL247484,TRICETIN
chembl:CHEMBL428789,CHEMBL428789
chembl:CHEMBL70,MORPHINE
chembl:CHEMBL75435,DEXKETOPROFEN
chembl:CHEMBL1614701,SELUMETINIB
chembl:CHEMBL571,KETOPROFEN
chembl:CHEMBL110458,MIGALASTAT
chembl:CHEMBL2110725,VINFLUNINE
chembl:CHEMBL1200338,PINACIDIL
chembl:CHEMBL533293,CHEMBL533293
chembl:CHEMBL221959,TOFACITINIB
chembl:CHEMBL2088731,CHEMBL2088731
chembl:CHEMBL71,CHLORPROMAZINE
HP:0011442,Abnormal central motor function
chembl:CHEMBL304818,DOCEBENONE
chembl:CHEMBL2105763,QUISINOSTAT
chembl:CHEMBL1539,SULFADOXINE
MONDO:0005229,bacterial infectious disease with sepsis
chembl:CHEMBL4209157,LIFIRAFENIB
chembl:CHEMBL337173,CHEMBL337173
chembl:CHEMBL596633,CHEMBL596633
chembl:CHEMBL212579,BENZAMIL
chembl:CHEMBL3188386,WNT-974
chembl:CHEMBL1255835,DIAMIDE
chembl:CHEMBL259615,CHEMBL259615
chembl:CHEMBL589715,CHEMBL589715
chembl:CHEMBL103552,LAVENDUSTIN A
chembl:CHEMBL1721885,SU-014813
chembl:CHEMBL594426,PHOTOFRIN
CHEBI:26878,tertiary alcohol
chembl:CHEMBL1333953,PHENYLMERCURIC ACETATE
chembl:CHEMBL107,COLCHICINE
HP:0010546,Muscle fibrillation
chembl:CHEMBL1200976,IDARUBICIN HYDROCHLORIDE
chembl:CHEMBL2105804,IMPLITAPIDE
chembl:CHEMBL533602,CHEMBL533602
chembl:CHEMBL197,DEXVERAPAMIL
chembl:CHEMBL1237021,LURASIDONE
chembl:CHEMBL576208,CHEMBL576208
chembl:CHEMBL1201731,NEBIVOLOL HYDROCHLORIDE
chembl:CHEMBL43185,PIPERINE
MONDO:0004323,muscular atrophy
chembl:CHEMBL545437,AMIBEGRON HYDROCHLORIDE
chembl:CHEMBL527620,CHEMBL527620
HP:0003743,Genetic anticipation
chembl:CHEMBL16,PHENYTOIN
chembl:CHEMBL661,ALPRAZOLAM
GO:0005354,galactose transmembrane transporter activity
chembl:CHEMBL1200732,AMCINONIDE
chembl:CHEMBL472,GLYBURIDE
chembl:CHEMBL1614,DESLANOSIDE
HP:0003438,Absent Achilles reflex
HP:0031826,Abnormal reflex
chembl:CHEMBL584,NELFINAVIR
chembl:CHEMBL405845,FURAFYLLINE
MONDO:0025699,Coffin-Siris syndrome 12
HGNC:7230,MRE11
chembl:CHEMBL528734,CHEMBL528734
chembl:CHEMBL28,APIGENIN
HP:0006932,Transient psychotic episodes
GO:0072757,cellular response to camptothecin
HGNC:17142,OPTN
chembl:CHEMBL554,LAPATINIB
chembl:CHEMBL1606022,SAPPANONE A TRIMETHYL ETHER
chembl:CHEMBL1615025,TAK-733
chembl:CHEMBL1939691,CHEMBL1939691
chembl:CHEMBL305380,BUPRANOLOL
chembl:CHEMBL151,LUTEOLIN
chembl:CHEMBL3545001,MK-8353
chembl:CHEMBL546576,CHEMBL546576
chembl:CHEMBL532160,CHEMBL532160
chembl:CHEMBL91732,ALDICARB
HGNC:26600,WDR81
HP:0001272,Cerebellar atrophy
CHEBI:35681,secondary alcohol
chembl:CHEMBL584442,CHEMBL584442
chembl:CHEMBL448213,LINURON
chembl:CHEMBL508102,CARBIMAZOLE
chembl:CHEMBL1434057,2-BENZOYL-5-METHOXYBENZOQUINONE
chembl:CHEMBL581044,CHEMBL581044
chembl:CHEMBL89445,TERPYRIDINE
chembl:CHEMBL579045,CHEMBL579045
chembl:CHEMBL52609,THYMIDINE
chembl:CHEMBL3601398,CGM-097
chembl:CHEMBL27508,CHEMBL27508
chembl:CHEMBL4297899,AZD-0156
chembl:CHEMBL571700,BIS(DIMETHYLAMINETHIOCARBONYL)MONOSULFIDE
chembl:CHEMBL508583,TRODUSQUEMINE
MONDO:0004285,pancreatic intraductal papillary-mucinous carcinoma
chembl:CHEMBL1487,ATORVASTATIN
chembl:CHEMBL592316,CHEMBL592316
chembl:CHEMBL1079460,CHEMBL1079460
MONDO:0011487,Huntington disease-like 3
chembl:CHEMBL3707219,REMETINOSTAT
chembl:CHEMBL20684,ABT-751
chembl:CHEMBL1230122,R-1487
chembl:CHEMBL546493,CHEMBL546493
chembl:CHEMBL750,ZONISAMIDE
HGNC:5173,HRAS
chembl:CHEMBL1335833,CHEMBL1335833
chembl:CHEMBL606111,ANTIBIOTIC
chembl:CHEMBL389621,HYDROCORTISONE
HGNC:48,ABCB7
chembl:CHEMBL1287853,FEDRATINIB
chembl:CHEMBL16901,HONOKIOL
chembl:CHEMBL806,FLUTAMIDE
chembl:CHEMBL3545049,BAY-1125976
chembl:CHEMBL3707320,ALECTINIB HYDROCHLORIDE
chembl:CHEMBL1631540,GSK163090
CHEBI:16737,creatinine
chembl:CHEMBL431770,ISTRADEFYLLINE
chembl:CHEMBL72365,CHEMBL72365
HGNC:8772,PDE10A
chembl:CHEMBL1099168,CHEMBL1099168
chembl:CHEMBL404108,LUMIRACOXIB
chembl:CHEMBL90983,TERAMEPROCOL
chembl:CHEMBL1738757,REBASTINIB
chembl:CHEMBL274921,CHEMBL274921
chembl:CHEMBL3545151,CC-223
HP:0012048,Oromandibular dystonia
chembl:CHEMBL1200418,DOBUTAMINE HYDROCHLORIDE
chembl:CHEMBL1371435,ISOEUGENITOL
chembl:CHEMBL3137345,DULIGOTUZUMAB
chembl:CHEMBL282042,SAQUINAVIR MESYLATE
chembl:CHEMBL1710,TRIFLUOPERAZINE HYDROCHLORIDE
chembl:CHEMBL531322,CHEMBL531322
MONDO:0005070,neoplasm
chembl:CHEMBL55814,ATHRAQUINONES A
chembl:CHEMBL1329443,CHEMBL1329443
chembl:CHEMBL457091,KASANOSIN B
MONDO:0012391,neuronal ceroid lipofuscinosis 8 northern epilepsy variant
chembl:CHEMBL885,EMTRICITABINE
chembl:CHEMBL1490,TRIHEXYPHENIDYL
HGNC:3312,ELAVL1
chembl:CHEMBL329673,CHEMBL329673
chembl:CHEMBL581677,CHEMBL581677
chembl:CHEMBL1334191,CHEMBL1334191
HP:0002080,Intention tremor
chembl:CHEMBL606166,CHEMBL606166
chembl:CHEMBL2181039,CHEMBL2181039
chembl:CHEMBL771,CYCLOSERINE
HP:0002131,Episodic ataxia
chembl:CHEMBL19954,CHEMBL19954
Reactome:R-HSA-211945,Phase I - Functionalization of compounds
chembl:CHEMBL4297189,CERALASERTIB
chembl:CHEMBL29197,CHEMBL29197
chembl:CHEMBL44,GENISTEIN
chembl:CHEMBL1554,DACTINOMYCIN
chembl:CHEMBL123,ELLIPTECINE
chembl:CHEMBL1643,RIBAVIRIN
chembl:CHEMBL1201066,VENLAFAXINE HYDROCHLORIDE
chembl:CHEMBL51483,GOSSYPOL
MONDO:0004187,nodular fasciitis
chembl:CHEMBL441282,PROPYLPYRAZOLETRIOL
chembl:CHEMBL1797707,CHEMBL1797707
chembl:CHEMBL57394,CHEMBL57394
HGNC:713,ARSA
UPHENO:0079834,abnormal irritability behavior
chembl:CHEMBL1908355,TENIDAP
chembl:CHEMBL456295,OXOPURPUREINE
HGNC:4910,HIF1A
chembl:CHEMBL192627,CHLORANIL
chembl:CHEMBL1481509,CHEMBL1481509
chembl:CHEMBL7301,FENRETINIDE
chembl:CHEMBL222519,NBQX
chembl:CHEMBL2097081,NITROPRUSSIDE
chembl:CHEMBL273103,CHEMBL273103
chembl:CHEMBL2105721,NIVOCASAN
MONDO:0018243,intellectual disability-hyperkinetic movement-truncal ataxia syndrome
chembl:CHEMBL2181046,CHEMBL2181046
chembl:CHEMBL4297771,INTERLEUKIN-10
chembl:CHEMBL1935538,CHEMBL1935538
chembl:CHEMBL1374504,"DALBERGIONE, 4-METHOXY-4'-HYDROXY-"
chembl:CHEMBL1365576,TETRASUL
HP:0032005,Hemidystonia
chembl:CHEMBL1256655,AMSACRINE HYDROCHLORIDE
HP:0003744,Genetic anticipation with paternal anticipation bias
chembl:CHEMBL1230020,PLX-4720
chembl:CHEMBL2165191,AZD-6482
HP:0002268,Paroxysmal dystonia
chembl:CHEMBL3989868,TUCATINIB
HP:0004373,Focal dystonia
chembl:CHEMBL574738,AST-487
chembl:CHEMBL611,TERAZOSIN
chembl:CHEMBL1465049,CHEMBL1465049
HGNC:1493,CARS1
CHEBI:48132,tetracenomycin
chembl:CHEMBL43,AMSACRINE
chembl:CHEMBL1372368,MUNDULONE ACETATE
chembl:CHEMBL1797712,CHEMBL1797712
chembl:CHEMBL3137346,PEGARGIMINASE
chembl:CHEMBL521027,CYPRODINIL
wikidata:Q31686490,ANDROSTANOLONE
chembl:CHEMBL595,PIOGLITAZONE
chembl:CHEMBL1116,RALOXIFENE HYDROCHLORIDE
chembl:CHEMBL1438389,CHEMBL1438389
chembl:CHEMBL600313,CHEMBL600313
chembl:CHEMBL3545401,X-82
chembl:CHEMBL461193,CHEMBL461193
chembl:CHEMBL513,CARMUSTINE
chembl:CHEMBL507237,CUCURBITACIN B
chembl:CHEMBL81782,CHEMBL81782
chembl:CHEMBL1224789,VOLVALERENAL D
chembl:CHEMBL537445,FENOTEROL HBR
chembl:CHEMBL1327821,ENPIROLINE
chembl:CHEMBL30816,DICHLOROISOPROTERENOL
chembl:CHEMBL149082,TRAMIPROSATE
chembl:CHEMBL77030,TYRPHOSTIN 47
chembl:CHEMBL917,FLOXURIDINE
chembl:CHEMBL78257,TYRPHOSTIN 51
chembl:CHEMBL471,SOTALOL
chembl:CHEMBL1556914,METHYL 7-DESHYDROXYPYROGALLIN-4-CARBOXYLATE
chembl:CHEMBL3099551,CMX-2043
chembl:CHEMBL12998,L-755507
chembl:CHEMBL3545332,CEP-2563
chembl:CHEMBL103,PROGESTERONE
chembl:CHEMBL1890813,METHABENZTHIAZURON
chembl:CHEMBL1873684,CHEMBL1873684
chembl:CHEMBL1079593,VS-5584
HGNC:6600,LIG3
chembl:CHEMBL483531,ALTENUSIN
CHEBI:26509,quinoline alkaloid
chembl:CHEMBL603154,CHEMBL603154
chembl:CHEMBL1363,ARFORMOTEROL
chembl:CHEMBL3301593,DECOGLURANT
chembl:CHEMBL570408,"1,4-DIMETHOXYANTHRAQUINONE"
HGNC:2345,CREB1
chembl:CHEMBL1614766,RO-4987655
HP:0001268,Mental deterioration
HGNC:746,ASL
chembl:CHEMBL261557,CHEMBL261557
chembl:CHEMBL2304041,SAGOPILONE
chembl:CHEMBL272980,MOCETINOSTAT
chembl:CHEMBL787,MONTELUKAST
chembl:CHEMBL1198857,VILANTEROL
chembl:CHEMBL101253,VATALANIB
chembl:CHEMBL1201026,ALBUTEROL SULFATE
MONDO:0003630,pancreatic serous cystadenocarcinoma
chembl:CHEMBL257748,CHEMBL257748
chembl:CHEMBL2108615,LAPULEUCEL-T
CHEBI:24436,guanidines
chembl:CHEMBL1790041,RANITIDINE
chembl:CHEMBL1346946,"DIBENZ[A,H]ANTHRACENE"
chembl:CHEMBL480328,CHEMBL480328
MONDO:0003414,skin pilomatrix carcinoma
HGNC:20,AARS1
Reactome:R-HSA-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL484853,CARNOSIC ACID
HP:0007286,Horizontal jerk nystagmus
chembl:CHEMBL169901,DEBRISOQUIN
chembl:CHEMBL1113,AMOXAPINE
chembl:CHEMBL18331,PIRENPERONE
HGNC:143,ACTC1
chembl:CHEMBL1743079,TEPROTUMUMAB
chembl:CHEMBL1421,DASATINIB
chembl:CHEMBL302449,GO-6976
chembl:CHEMBL75880,PERHEXILINE
chembl:CHEMBL338604,C-1311
chembl:CHEMBL384467,DEXAMETHASONE
chembl:CHEMBL1094966,PIRBUTEROL
chembl:CHEMBL1336287,"3,4-DIDESMETHYL-5-DESHYDROXY-3'-ETHOXYSCLEROIN"
chembl:CHEMBL1200969,DUTASTERIDE
chembl:CHEMBL727,THIOGUANINE
chembl:CHEMBL206834,BAFETINIB
chembl:CHEMBL133342,(S)-ROSCOVITINE
chembl:CHEMBL1200760,BALSALAZIDE DISODIUM
MONDO:0006684,brain edema
chembl:CHEMBL3334567,SAVOLITINIB
chembl:CHEMBL98,VORINOSTAT
chembl:CHEMBL382300,ORTATAXEL
chembl:CHEMBL88055,RIMITEROL
MONDO:0005299,brain ischemia
chembl:CHEMBL530049,CHEMBL530049
chembl:CHEMBL392068,CHEMBL392068
chembl:CHEMBL222556,CHEMBL222556
chembl:CHEMBL567,PERPHENAZINE
chembl:CHEMBL280998,CATECHOL
chembl:CHEMBL2403108,CERITINIB
chembl:CHEMBL45830,MILTIRONE
chembl:CHEMBL3286830,LORLATINIB
chembl:CHEMBL1381098,1-NAPHTHYLISOTHIOCYANATE
chembl:CHEMBL16687,CGS-15943
MONDO:0005086,renal cell carcinoma
HGNC:3775,FMR1
chembl:CHEMBL1272,REPAGLINIDE
chembl:CHEMBL208427,SOLABEGRON
chembl:CHEMBL1200781,CITALOPRAM HYDROBROMIDE
chembl:CHEMBL4297857,AB-928
chembl:CHEMBL1551666,PROPYLENE GLYCOL MONOSTEARATE
HP:0033683,Jaw hyperreflexia
chembl:CHEMBL1255582,FIPAMEZOLE
chembl:CHEMBL580609,CHEMBL580609
chembl:CHEMBL412010,DERRUBONE
HP:0100710,Impulsivity
chembl:CHEMBL80830,BUCILLAMINE
chembl:CHEMBL1270169,CHEMBL1270169
HP:0007034,Generalized hyperreflexia
chembl:CHEMBL79993,Z-PRO-PROLINAL
chembl:CHEMBL219553,GIGANTOL
chembl:CHEMBL2107339,ESMIRTAZAPINE MALEATE
HGNC:6250,KCNH1
chembl:CHEMBL1289926,AXITINIB
chembl:CHEMBL1417019,MITOXANTRONE HYDROCHLORIDE
chembl:CHEMBL2311030,ERGOLOID MESYLATES
HGNC:89,ACADM
chembl:CHEMBL97453,WEDELOLACTONE
HP:0002451,Limb dystonia
chembl:CHEMBL1201237,LEVOBUNOLOL
CHEBI:65191,second generation antipsychotic
chembl:CHEMBL1515,METHIMAZOLE
chembl:CHEMBL477197,HEMATOXYLIN
chembl:CHEMBL772,RESERPINE
chembl:CHEMBL1479,DANAZOL
chembl:CHEMBL600956,CHEMBL600956
chembl:CHEMBL3039525,GOLVATINIB
chembl:CHEMBL588,FENOLDOPAM
chembl:CHEMBL978,METHACHOLINE
chembl:CHEMBL386630,TESTOSTERONE
chembl:CHEMBL191044,BENZOXATHIAN
chembl:CHEMBL3301587,DURVALUMAB
chembl:CHEMBL3663929,NAQUOTINIB
chembl:CHEMBL3545159,R-333
chembl:CHEMBL23327,PURVALANOLA
chembl:CHEMBL2177350,NEOPETROFORMYNE A
chembl:CHEMBL366861,FUMARPROTOCETRARIC ACID
chembl:CHEMBL494826,METHYLCURCUMIN
chembl:CHEMBL1358,FULVESTRANT
chembl:CHEMBL1084172,VILANTEROL TRIFENATATE
chembl:CHEMBL1518159,3-METHOXYCATECHOL
chembl:CHEMBL600694,CHEMBL600694
chembl:CHEMBL1180,O-DEMETHYLATED ADAPALENE
chembl:CHEMBL601385,CHEMBL601385
chembl:CHEMBL1525298,DIETHYLSTILBESTROL DIPROPIONATE
chembl:CHEMBL457504,CHEMBL457504
MONDO:0012444,neurodegeneration with brain iron accumulation 2B
chembl:CHEMBL391997,CAPSAZEPINE
chembl:CHEMBL373872,BEAUVERICIN
chembl:CHEMBL336095,CHEMBL336095
MONDO:0002280,anemia
HP:0030219,Semantic dementia
chembl:CHEMBL515763,CHEMBL515763
chembl:CHEMBL468,THALIDOMIDE
chembl:CHEMBL4297522,PEMIGATINIB
HP:0200147,Neuronal loss in basal ganglia
chembl:CHEMBL178,DAUNORUBICIN
chembl:CHEMBL1322218,PROCATEROL HYDROCHLORIDE
MONDO:0003441,dystonic disorder
HGNC:3767,FLT4
chembl:CHEMBL2347958,CHEMBL2347958
chembl:CHEMBL346631,CEP-7055
CHEBI:57947,creatine zwitterion
HGNC:4010,FUS
chembl:CHEMBL75967,PENTACHLOROPHENOL
chembl:CHEMBL222102,KU-55933
chembl:CHEMBL4297523,PIROMELATINE
chembl:CHEMBL68534,CHEMBL68534
chembl:CHEMBL55659,ANTHRAQUINONE
Reactome:R-CFA-390651,Dopamine receptors
HGNC:2529,CTSD
chembl:CHEMBL269733,DEPHOSTATIN
chembl:CHEMBL7463,GF-109203
chembl:CHEMBL2108110,THROMBIN
chembl:CHEMBL255863,NILOTINIB
chembl:CHEMBL1289494,TIVOZANIB
chembl:CHEMBL29166,CHEMBL29166
chembl:CHEMBL1614725,TAK-285
chembl:CHEMBL364713,NOSCAPINE
HGNC:1908,VPS13A
chembl:CHEMBL156897,CANTHIN-6-ONE
chembl:CHEMBL469912,PUROMYCIN
chembl:CHEMBL1390716,CHEMBL1390716
chembl:CHEMBL1492017,CHEMBL1492017
chembl:CHEMBL1221986,WITHAFERIN A
GO:0098708,glucose import across plasma membrane
chembl:CHEMBL3989870,BERZOSERTIB
chembl:CHEMBL833,TICLOPIDINE
chembl:CHEMBL1201160,RITODRINE HYDROCHLORIDE
chembl:CHEMBL601773,DIHYDROERGOCRISTINE
chembl:CHEMBL4297326,SLX-4090
chembl:CHEMBL960,LEFLUNOMIDE
chembl:CHEMBL1255663,RACEPINEPHRINE HYDROCHLORIDE
chembl:CHEMBL3545235,SIMOTINIB
HP:0007089,Facial-lingual fasciculations
chembl:CHEMBL1201129,DECITABINE
chembl:CHEMBL118,CELECOXIB
chembl:CHEMBL93353,ARISTOLOCHIC ACID
Reactome:R-HSA-1614517,Sulfide oxidation to sulfate
chembl:CHEMBL2109399,T-DM1
chembl:CHEMBL1478,LITHOCHOLIC ACID
HGNC:18856,CREB3L1
MONDO:0005260,autism
chembl:CHEMBL48449,CANTHARIDIN
Reactome:R-DRE-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL547833,CHEMBL547833
HP:0000666,Horizontal nystagmus
chembl:CHEMBL499,TIMOLOL
chembl:CHEMBL1330729,CLENBUTEROL HYDROCHLORIDE
chembl:CHEMBL1743047,NECITUMUMAB
CHEBI:48626,pyranoindolizinoquinoline
HP:0002075,Dysdiadochokinesis
CHEBI:17287,N-phosphocreatine
chembl:CHEMBL704,MESALAMINE
chembl:CHEMBL463,AMINOHIPPURIC ACID
HGNC:115,ACLY
HGNC:1382,CA8
HP:0001824,Weight loss
chembl:CHEMBL1288831,PESUDOGINSENOSIDE RP1 METHYL ESTER
chembl:CHEMBL3545325,SAR-125844
chembl:CHEMBL839,CARTEOLOL
MONDO:0005560,brain disorder
chembl:CHEMBL677,LEVONORDEFRIN
chembl:CHEMBL1722838,XANTHOANGELOL F
chembl:CHEMBL103667,DORAMAPIMOD
chembl:CHEMBL184074,CHEMBL184074
chembl:CHEMBL3989908,ENASIDENIB
chembl:CHEMBL581194,CHEMBL581194
chembl:CHEMBL1200745,OXPRENOLOL HYDROCHLORIDE
HP:0033206,Hyperactive Achilles reflex
chembl:CHEMBL525103,CHEMBL525103
chembl:CHEMBL47,VITAMIN E
chembl:CHEMBL595227,CHEMBL595227
chembl:CHEMBL399121,HESPERETIN
chembl:CHEMBL576412,CHEMBL576412
chembl:CHEMBL1236682,REFAMETINIB
chembl:CHEMBL210208,PYROGALLOL RED
chembl:CHEMBL54661,FLUPENTIXOL
CHEBI:176497,geroprotector
HP:0002356,Writer's cramp
chembl:CHEMBL1601846,CHEMBL1601846
MONDO:0013866,neuronal ceroid lipofuscinosis 11
chembl:CHEMBL2336325,VISTUSERTIB
chembl:CHEMBL408194,OBATOCLAX
chembl:CHEMBL3301576,PEGPLERANIB SODIUM
chembl:CHEMBL3813873,PEXIDARTINIB
wikidata:Q4767903,ANNAMYCIN
chembl:CHEMBL1201001,MECHLORETHAMINE HYDROCHLORIDE
chembl:CHEMBL520733,SEMAGACESTAT
HGNC:823,ATP5F1A
chembl:CHEMBL687,ACETYLSULFANILAMIDE
chembl:CHEMBL275516,CANTHARIDIC_ACID
chembl:CHEMBL64249,CLOROTEPINE
chembl:CHEMBL480558,GSI-136
HP:0000716,Depression
CHEBI:46245,coenzyme Q10
chembl:CHEMBL1481,GLIMEPIRIDE
chembl:CHEMBL3306803,LUMATEPERONE
chembl:CHEMBL493737,METHYLINOSITOL
chembl:CHEMBL49120,PD-0166285
chembl:CHEMBL24955,BEXLOSTERIDE
chembl:CHEMBL1408276,CHEMBL1408276
chembl:CHEMBL1393,SPIRONOLACTONE
chembl:CHEMBL1645462,AC-480
Reactome:R-CEL-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL2036119,CHEMBL2036119
chembl:CHEMBL289480,RILMENIDINE
chembl:CHEMBL581152,CHEMBL581152
HGNC:38606,BECN2
chembl:CHEMBL2387080,TASELISIB
chembl:CHEMBL3545284,CERDULATINIB
chembl:CHEMBL1306556,CHEMBL1306556
chembl:CHEMBL601146,CHEMBL601146
chembl:CHEMBL2103743,TOFACITINIB CITRATE
chembl:CHEMBL1950554,BINODENOSON
chembl:CHEMBL3989862,PEFCALCITOL
chembl:CHEMBL601367,CHEMBL601367
chembl:CHEMBL1738797,ALECTINIB
chembl:CHEMBL1201063,PROPAFENONE HYDROCHLORIDE
chembl:CHEMBL588327,CHEMBL588327
HGNC:7132,KMT2A
chembl:CHEMBL1517,OXYTETRACYCLINE
chembl:CHEMBL217092,SARACATINIB
chembl:CHEMBL15193,LAPACHOL
chembl:CHEMBL38380,FASUDIL
chembl:CHEMBL897,PROBENECID
chembl:CHEMBL2103827,DROXIDOPA
chembl:CHEMBL24828,VANDETANIB
chembl:CHEMBL2094652,CHEMBL2094652
MONDO:0005077,pertussis
chembl:CHEMBL252164,LUMINESPIB
chembl:CHEMBL285674,ESTAZOLAM
chembl:CHEMBL1451,TRIAMCINOLONE
chembl:CHEMBL300555,SPIROXATRINE
chembl:CHEMBL180022,NERATINIB
chembl:CHEMBL635,PREDNISONE
chembl:CHEMBL52347,"1,2-NAPHTHOQUINONE"
chembl:CHEMBL221753,BENZETHONIUM CHLORIDE
chembl:CHEMBL1425995,DIFLUFENICAN
HP:0002078,Truncal ataxia
chembl:CHEMBL116955,CONGO RED
GO:0097333,response to olanzapine
chembl:CHEMBL367149,DOCONEXENT
CHEBI:16389,ubiquinones
chembl:CHEMBL2103826,DAVUNETIDE
HGNC:18301,SLC2A14
chembl:CHEMBL1201346,BALSALAZIDE
chembl:CHEMBL48166,HOMIDIUM
chembl:CHEMBL1185568,DITHIAZANINE
MONDO:0019303,premature aging syndrome
chembl:CHEMBL1287980,CHEMBL1287980
chembl:CHEMBL596380,CHEMBL596380
chembl:CHEMBL1989853,CHEMBL1989853
chembl:CHEMBL283552,FLUOROSALAN
chembl:CHEMBL1086397,CHEMBL1086397
HP:0011006,Abnormal morphology of the musculature of the neck
chembl:CHEMBL3833373,AVELUMAB
chembl:CHEMBL482968,ENMD-2076
chembl:CHEMBL3137320,TALAZOPARIB
chembl:CHEMBL24,ATENOLOL
chembl:CHEMBL212948,DAMNACANTHAL
chembl:CHEMBL1614707,MUBRITINIB
chembl:CHEMBL289228,TIPIFARNIB
chembl:CHEMBL3545137,PF-00477736
chembl:CHEMBL292303,D-TRYPTOPHAN
HP:0000473,Torticollis
MONDO:0011963,Joubert syndrome 2
chembl:CHEMBL470881,OXOGLAUCINE
chembl:CHEMBL493863,CHEMBL493863
chembl:CHEMBL2106468,TRICETAMIDE
chembl:CHEMBL1263,SALMETEROL
chembl:CHEMBL3545022,ULIXERTINIB
chembl:CHEMBL533965,CHEMBL533965
chembl:CHEMBL1200970,ETHOPROPAZINE HYDROCHLORIDE
chembl:CHEMBL155622,NIPRADILOL
MONDO:0043510,brain injury
chembl:CHEMBL354349,ACRIFLAVINE
chembl:CHEMBL356388,ETAZOLATE
chembl:CHEMBL38827,LUMEFANTRINE
HGNC:12666,VCP
CHEBI:139592,tertiary alpha-hydroxy ketone
chembl:CHEMBL285063,CHEMBL285063
chembl:CHEMBL1185260,NITROBLUE TETRAZOLIUM
wikidata:Q29005931,HERCEPTIN
chembl:CHEMBL535,SUNITINIB
chembl:CHEMBL2105747,TOZADENANT
chembl:CHEMBL578061,CHEMBL578061
chembl:CHEMBL4297618,GRANOTAPIDE
chembl:CHEMBL2105737,SONIDEGIB
HP:0002500,Abnormal cerebral white matter morphology
chembl:CHEMBL428647,PACLITAXEL
MONDO:0005081,preeclampsia
chembl:CHEMBL578502,CHEMBL578502
chembl:CHEMBL17157,TERFENADINE
chembl:CHEMBL286738,IROSUSTAT
chembl:CHEMBL36327,EPICATECHIN GALLATE
chembl:CHEMBL151649,PHENETHYLISOTHIOCYANATE
chembl:CHEMBL35482,CHEMBL35482
chembl:CHEMBL4297067,FLUORESCEIN
MONDO:0002235,eyelid neoplasm
chembl:CHEMBL550,PILOCARPINE
chembl:CHEMBL375270,CHEMBL375270
chembl:CHEMBL471225,CHEMBL471225
chembl:CHEMBL537,HYDROQUINONE
HGNC:13919,BAG6
chembl:CHEMBL1689,TOLAZOLINE HYDROCHLORIDE
chembl:CHEMBL3545195,LY-3009120
HGNC:132,ACTB
MONDO:0100545,hereditary neurological disease
HGNC:865,ATP6V0A1
chembl:CHEMBL1679,LEUCOVORIN
chembl:CHEMBL207456,PITTSBURGH COMPOUND B
chembl:CHEMBL292702,MAYTANSINE
chembl:CHEMBL3545335,AG-13958
chembl:CHEMBL1002,LEVOSALBUTAMOL
chembl:CHEMBL2107863,RINDOPEPIMUT
chembl:CHEMBL1169388,CHEMBL1169388
chembl:CHEMBL590168,CHEMBL590168
chembl:CHEMBL473773,CHEMBL473773
chembl:CHEMBL1742992,BLINATUMOMAB
MONDO:0002816,adrenal cortex disorder
chembl:CHEMBL214154,MAYTANSINOL
UPHENO:0074367,abnormally decreased rate of motor coordination
chembl:CHEMBL182,GANCICLOVIR
chembl:CHEMBL354676,DIPHENYLUREA
chembl:CHEMBL279260,RAFABEGRON
HGNC:5241,HSPA8
chembl:CHEMBL405110,METHYLTHIONINIUM CHLORIDE
chembl:CHEMBL1437,NOREPINEPHRINE
chembl:CHEMBL1200795,CLEMASTINE FUMARATE
MONDO:0002562,demyelinating disease
chembl:CHEMBL453818,CHEMBL453818
chembl:CHEMBL1743072,SOLANEZUMAB
CHEBI:26979,organic heterotricyclic compound
chembl:CHEMBL502529,NAKIJIQUINONES G
chembl:CHEMBL4297900,AZD-4785
HGNC:2661,DAB1
chembl:CHEMBL582355,ETHACRIDINE LACTATE
chembl:CHEMBL73711,CHEMBL73711
chembl:CHEMBL63354,AMENTOFLAVONE
HP:0012049,Laryngeal dystonia
HGNC:494,ANK3
chembl:CHEMBL2107861,ZALUTUMUMAB
chembl:CHEMBL578504,CHEMBL578504
chembl:CHEMBL526034,CHEMBL526034
MONDO:0016305,atypical pantothenate kinase-associated neurodegeneration
HGNC:30829,TUBB2B
chembl:CHEMBL2107387,VORTIOXETINE HYDROBROMIDE
chembl:CHEMBL1256759,5-NITRO-2-PHENYLPROPYLAMINOBENZOIC ACID [NPPB]
chembl:CHEMBL2063687,CHEMBL2063687
chembl:CHEMBL1893890,QUINALPHOS
chembl:CHEMBL1438439,IRIGENOL
chembl:CHEMBL275835,DARBUFELONE
chembl:CHEMBL3707227,ATEZOLIZUMAB
HP:0030186,Kinetic tremor
chembl:CHEMBL1241855,RIGOSERTIB
chembl:CHEMBL3644587,2X-121
chembl:CHEMBL274654,ORANTINIB
chembl:CHEMBL319244,CAFFEIC ACID PHENETHYL ESTER
chembl:CHEMBL250711,OLEOYL DOPAMINE
chembl:CHEMBL583912,(-)-EPICATECHIN
chembl:CHEMBL197669,ST1535
chembl:CHEMBL2354444,PIRARUBICIN
chembl:CHEMBL134,CLONIDINE
chembl:CHEMBL2094422,CHEMBL2094422
chembl:CHEMBL1834675,SPHAEROPSIDIN A
chembl:CHEMBL1543865,CHEMBL1543865
chembl:CHEMBL3545200,S-222611
chembl:CHEMBL2364651,TOVETUMAB
chembl:CHEMBL580819,CHEMBL580819
chembl:CHEMBL566,URACIL
MONDO:0013674,neurodegeneration with brain iron accumulation 4
chembl:CHEMBL3137309,VENETOCLAX
Reactome:R-GGA-390650,Histamine receptors
chembl:CHEMBL300389,CHEMBL300389
chembl:CHEMBL1288652,5-BENZYLOXYTRYPTAMINE
chembl:CHEMBL1076347,TRICLOCARBAN
chembl:CHEMBL1368322,PARAROSANILINE
Reactome:R-GGA-500753,Pyrimidine biosynthesis
chembl:CHEMBL403989,TG100-801
chembl:CHEMBL121,ROSIGLITAZONE
Reactome:R-DDI-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL69863,PICEATANNOL
chembl:CHEMBL513389,ICI-118551
GO:0005515,protein binding
chembl:CHEMBL1367933,CHEMBL1367933
chembl:CHEMBL356066,DACINOSTAT
HGNC:3999,FTL
HP:0007018,Attention deficit hyperactivity disorder
MONDO:0000837,bone resorption disease
chembl:CHEMBL2109390,MAB-425
chembl:CHEMBL3833344,GANCOTAMAB
chembl:CHEMBL1567,SUNITINIB MALATE
chembl:CHEMBL15870,INDOPROFEN
HP:0010868,Ocular dyssynergia
chembl:CHEMBL274064,SB-220025
chembl:CHEMBL1950553,SONEDENOSON
chembl:CHEMBL1789941,RUXOLITINIB
chembl:CHEMBL1358137,CHEMBL1358137
chembl:CHEMBL2105275,PROPYLHEXEDRINE
chembl:CHEMBL1393904,MIRIPIRIUM
chembl:CHEMBL1399,ANASTROZOLE
chembl:CHEMBL4204794,AVAPRITINIB
chembl:CHEMBL1200916,THIORIDAZINE HYDROCHLORIDE
chembl:CHEMBL549,CITALOPRAM
HGNC:1424,CAD
chembl:CHEMBL607309,CHEMBL607309
chembl:CHEMBL1380,ABACAVIR
chembl:CHEMBL1743004,CRENEZUMAB
MONDO:0005395,movement disorder
chembl:CHEMBL340807,HARMALINE
chembl:CHEMBL87333,CIS-RESVERATROL
chembl:CHEMBL1200595,CHLORPHENTERMINE HYDROCHLORIDE
chembl:CHEMBL535650,MEFLOQUINE HYDROCHLORIDE
chembl:CHEMBL1095515,SCLEROTIORIN
chembl:CHEMBL602987,CHEMBL602987
chembl:CHEMBL521686,OLAPARIB
chembl:CHEMBL28509,EDELFOSINE
chembl:CHEMBL586078,CHEMBL586078
chembl:CHEMBL467590,GETIACAULEIN
chembl:CHEMBL1542,AZATHIOPRINE
chembl:CHEMBL562318,MARDEPODECT
chembl:CHEMBL39878,CHEMBL39878
chembl:CHEMBL1201115,ESMOLOL HYDROCHLORIDE
chembl:CHEMBL413,SIROLIMUS
chembl:CHEMBL1481873,PHOSMET
chembl:CHEMBL603469,LESTAURTINIB
Reactome:R-DME-71403,Citric acid cycle (TCA cycle)
chembl:CHEMBL1118,DESVENLAFAXINE
chembl:CHEMBL1255778,BENSERAZIDE HYDROCHLORIDE
HGNC:11167,SNTA1
chembl:CHEMBL490,PAROXETINE
MONDO:0007256,hepatocellular carcinoma
MONDO:0004994,cardiomyopathy
chembl:CHEMBL2103879,GANETESPIB
chembl:CHEMBL1613209,CEAROIN
HP:0000735,Impaired social interactions
chembl:CHEMBL53,APOMORPHINE
chembl:CHEMBL318782,DICHLON
chembl:CHEMBL1200870,TIMOLOL MALEATE
chembl:CHEMBL1256786,FORMOTEROL
HP:0006962,"Gait instability, worse in the dark"
chembl:CHEMBL2104988,TIPELUKAST
HP:0002474,Expressive language delay
HGNC:7464,MTNR1B
chembl:CHEMBL429095,CHEMBL429095
chembl:CHEMBL1797711,CHEMBL1797711
chembl:CHEMBL1546228,CHEMBL1546228
chembl:CHEMBL1091644,LINSITINIB
chembl:CHEMBL686,MEFENAMIC ACID
chembl:CHEMBL3545021,ANLOTINIB
HP:0001618,Dysphonia
chembl:CHEMBL2079588,TELATINIB
chembl:CHEMBL1899565,GEOPYXIN A
chembl:CHEMBL1200751,MERCAPTOPURINE
chembl:CHEMBL177820,TETRABROMOBENZOTRIAZOLE
chembl:CHEMBL406381,KRN-633
chembl:CHEMBL50588,EMETINE
MONDO:0018760,DeSanto-Shinawi syndrome
chembl:CHEMBL1200996,MEPHENTERMINE SULFATE
chembl:CHEMBL1255834,CHEMBL1255834
chembl:CHEMBL533226,CHEMBL533226
chembl:CHEMBL538943,VINORELBINE TARTRATE
chembl:CHEMBL3544956,PYROTINIB
chembl:CHEMBL506247,TANNIC ACID
chembl:CHEMBL2104449,SARAKALIM
chembl:CHEMBL150,KAEMPFEROL
chembl:CHEMBL1750,CLOFARABINE
chembl:CHEMBL393417,DEGUELIN
MONDO:0006732,drug-induced dyskinesia
HP:0010544,Vertical nystagmus
chembl:CHEMBL1090771,AVAGACESTAT
chembl:CHEMBL555017,GAMBOGIC ACID
chembl:CHEMBL1447476,BITHIONOLATE SODIUM
chembl:CHEMBL2104986,TEDATIOXETINE
HGNC:61,ABCD1
chembl:CHEMBL1980297,ILORASERTIB
chembl:CHEMBL1201577,CETUXIMAB
chembl:CHEMBL2103863,ABEXINOSTAT
chembl:CHEMBL1412489,CHEMBL1412489
chembl:CHEMBL1117,IDARUBICIN
chembl:CHEMBL1624,LEVOTHYROXINE
chembl:CHEMBL4297187,DERAZANTINIB
HP:0001284,Areflexia
chembl:CHEMBL1200710,CLOMIPRAMINE HYDROCHLORIDE
chembl:CHEMBL1516474,TEGASEROD MALEATE
chembl:CHEMBL505670,CHEMBL505670
chembl:CHEMBL4298032,MEDI-4276
chembl:CHEMBL485053,LEUCETTAMINE B
chembl:CHEMBL34241,ROTTLERIN
MONDO:0010375,"developmental and epileptic encephalopathy, 8"
HGNC:1034,BECN1
chembl:CHEMBL4298105,VALZIFLOCEPT
chembl:CHEMBL1200981,EPIRUBICIN HYDROCHLORIDE
chembl:CHEMBL1889303,CHEMBL1889303
Reactome:R-XTR-211945,Phase I - Functionalization of compounds
chembl:CHEMBL258844,CHEMBL258844
MONDO:0021135,rare or common
chembl:CHEMBL1650619,PYRITHIONE
chembl:CHEMBL1397308,CHEMBL1397308
chembl:CHEMBL1519327,ZIRAM
chembl:CHEMBL545,ALCOHOL
HP:0007000,Morning myoclonic jerks
chembl:CHEMBL293030,BUNOLOL
chembl:CHEMBL56731,CHEMBL56731
chembl:CHEMBL150894,CEP-5214
chembl:CHEMBL1908391,MASITINIB
chembl:CHEMBL1568,FLUDARABINE
chembl:CHEMBL2137046,AFIMOXIFENE
chembl:CHEMBL449782,CEPHARANTHINE
chembl:CHEMBL1201049,ECONAZOLE NITRATE
chembl:CHEMBL728,PROCHLORPERAZINE
chembl:CHEMBL3559672,RAUWOLFIA SERPENTINA
chembl:CHEMBL1379900,CHEMBL1379900
HP:0006844,Absent patellar reflexes
chembl:CHEMBL3545177,AZD-0424
chembl:CHEMBL3039518,BATEFENTEROL
HGNC:11205,SP1
chembl:CHEMBL59356,ATRELEUTON
chembl:CHEMBL1708,PAROXETINE HYDROCHLORIDE
chembl:CHEMBL584883,CHEMBL584883
chembl:CHEMBL4113131,ENSARTINIB
HGNC:634,AQP2
chembl:CHEMBL263116,DIMETHYL YELLOW
chembl:CHEMBL471498,MITIGLINIDE
chembl:CHEMBL1431,METFORMIN
chembl:CHEMBL4297310,ONC-201
GO:1904659,glucose transmembrane transport
chembl:CHEMBL8483,CHEMBL8483
chembl:CHEMBL434063,CHEMBL434063
chembl:CHEMBL828,PHENOTHIAZINE
HP:0010867,Dyssynergia
chembl:CHEMBL1201631,INSULIN
chembl:CHEMBL343448,ROMIDEPSIN
chembl:CHEMBL3039504,NINTEDANIB ESYLATE
chembl:CHEMBL15177,MK-571
chembl:CHEMBL339587,CHEMBL339587
chembl:CHEMBL491473,CEDIRANIB
chembl:CHEMBL1606,CHEMBL1606
chembl:CHEMBL466465,CHEMBL466465
HGNC:5237,HSPA4
chembl:CHEMBL1448,NICLOSAMIDE
chembl:CHEMBL359164,TROXACITABINE
chembl:CHEMBL297453,EPIGALOCATECHIN GALLATE
chembl:CHEMBL4297494,GSK-3117391
chembl:CHEMBL545315,CANERTINIB DIHYDROCHLORIDE
chembl:CHEMBL238188,OSAJIN
chembl:CHEMBL388676,CAPTAN
chembl:CHEMBL123292,CYCLOHEXIMIDE
chembl:CHEMBL170988,PHENFORMIN
MONDO:0005574,tauopathy
chembl:CHEMBL1201,THIOTHIXENE
chembl:CHEMBL3707277,DEPATUXIZUMAB MAFODOTIN
chembl:CHEMBL379300,A-443654
MONDO:0008948,cerebrotendinous xanthomatosis
chembl:CHEMBL1684984,PA-799
chembl:CHEMBL414804,OXALIPLATIN
chembl:CHEMBL93,ZILEUTON
chembl:CHEMBL49338,DIFLUBENZURON
HGNC:163,ACTN1
chembl:CHEMBL1173655,AFATINIB
chembl:CHEMBL373742,VASOPRESSIN
MONDO:0011175,Friedreich ataxia 2
chembl:CHEMBL26260,BETA-NAPHTHOFLAVONE
chembl:CHEMBL3218576,COPANLISIB
chembl:CHEMBL1444,LETROZOLE
chembl:CHEMBL8260,BAICALEIN
chembl:CHEMBL1575,ESTRAMUSTINE
chembl:CHEMBL222863,OUABAIN
chembl:CHEMBL1200586,PRILOCAINE HYDROCHLORIDE
chembl:CHEMBL1565133,SANGUINARINE SULFATE
chembl:CHEMBL3963485,ROGARATINIB
chembl:CHEMBL578928,CHEMBL578928
chembl:CHEMBL227075,DIHYDROTANSHINONE I
chembl:CHEMBL810,TEMOZOLOMIDE
chembl:CHEMBL283196,ALPHA-NAPHTHOFLAVONE
chembl:CHEMBL1201832,ROMIPLOSTIM
chembl:CHEMBL12318,CLODRONIC ACID
MONDO:0018307,neurodegeneration with brain iron accumulation
chembl:CHEMBL2108576,BAPINEUZUMAB
chembl:CHEMBL13045,CHELERYTHRINE
chembl:CHEMBL407874,6-O-BENZYLGUANINE
chembl:CHEMBL581880,CHEMBL581880
chembl:CHEMBL781,MAZINDOL
chembl:CHEMBL128748,DIMETHYLCURCUMIN
chembl:CHEMBL462861,CHEMBL462861
chembl:CHEMBL1997335,CHEMBL1997335
HGNC:1867,CETN2
chembl:CHEMBL3545264,LY-2874455
chembl:CHEMBL416038,CHEMBL416038
chembl:CHEMBL764,NORDEFRIN
chembl:CHEMBL3894518,AZD-8835
chembl:CHEMBL1228,OXYPHENBUTAZONE
chembl:CHEMBL13,METOPROLOL
chembl:CHEMBL1201740,NILOTINIB HYDROCHLORIDE MONOHYDRATE
HGNC:76,ABL1
chembl:CHEMBL1096380,PLINABULIN
HP:0000643,Blepharospasm
chembl:CHEMBL4297844,TRASTUZUMAB DERUXTECAN
chembl:CHEMBL1484251,CHLORHEXIDINE HYDROCHLORIDE
chembl:CHEMBL1200485,SORAFENIB TOSYLATE
chembl:CHEMBL113150,CETRIMIDE
chembl:CHEMBL1200645,ETOPOSIDE PHOSPHATE
chembl:CHEMBL1789842,INDACATEROL MALEATE
GO:0042995,cell projection
chembl:CHEMBL307893,CHEMBL307893
chembl:CHEMBL1426508,CHEMBL1426508
chembl:CHEMBL93240,METITEPINE
HP:0002540,Inability to walk
chembl:CHEMBL581574,CHEMBL581574
chembl:CHEMBL1034,DICLOFENAC SODIUM
chembl:CHEMBL3137308,PEFICITINIB
chembl:CHEMBL1790006,TOLONIUM CHLORIDE
chembl:CHEMBL1201733,PAZOPANIB HYDROCHLORIDE
chembl:CHEMBL1334033,PERHEXILINE MALEATE
chembl:CHEMBL3187365,ASENAPINE
chembl:CHEMBL1201124,KETOROLAC TROMETHAMINE
GO:0035579,specific granule membrane
chembl:CHEMBL2103840,DINACICLIB
chembl:CHEMBL24983,CHEMBL24983
chembl:CHEMBL848,LENALIDOMIDE
chembl:CHEMBL1657,TAZAROTENE
chembl:CHEMBL1200725,SERTACONAZOLE NITRATE
chembl:CHEMBL45068,PHLORETIN
chembl:CHEMBL45,MELATONIN
chembl:CHEMBL1386,TRANSPLATIN
chembl:CHEMBL1554531,4-METHOXYDALBERGIONE
chembl:CHEMBL16024,DESMEDIPHAM
chembl:CHEMBL1466186,CHEMBL1466186
chembl:CHEMBL275638,FLAVONE
CHEBI:26895,tetracyclines
chembl:CHEMBL221907,CUDRAFLAVONE B
Reactome:R-MMU-211945,Phase I - Functionalization of compounds
HGNC:2077,CLN6
chembl:CHEMBL3545396,BMS-690514
HP:0007859,Congenital horizontal nystagmus
chembl:CHEMBL584458,CHEMBL584458
chembl:CHEMBL1765740,CHEMBL1765740
chembl:CHEMBL591126,CHEMBL591126
chembl:CHEMBL569864,CHEMBL569864
chembl:CHEMBL15594,ARACHIDONIC ACID
chembl:CHEMBL121626,TOLFENAMIC ACID
chembl:CHEMBL522892,DOVITINIB
chembl:CHEMBL478960,MACLURAXANTHONE
chembl:CHEMBL1535,HYDROXYCHLOROQUINE
chembl:CHEMBL62136,T091317
chembl:CHEMBL514499,GW843682X
chembl:CHEMBL79,LIDOCAINE
chembl:CHEMBL56367,NIMESULIDE
chembl:CHEMBL2396661,ALPELISIB
chembl:CHEMBL4298013,ELGEMTUMAB
HGNC:3214,EEF2
chembl:CHEMBL227959,CHEMBL227959
chembl:CHEMBL1751,DIGOXIN
chembl:CHEMBL99,TRICHOSTATIN
Reactome:R-HSA-390650,Histamine receptors
chembl:CHEMBL98350,LY-294002
chembl:CHEMBL223228,EFAVIRENZ
HGNC:12698,VLDLR
chembl:CHEMBL86464,CHEMBL86464
chembl:CHEMBL3545339,FRUQUINTINIB
chembl:CHEMBL1200893,PROTOKYLOL HYDROCHLORIDE
chembl:CHEMBL450786,PHA-665752
chembl:CHEMBL211456,EPHEDRINE
chembl:CHEMBL930,GLUTAMINE
MONDO:0005752,epidural abscess
chembl:CHEMBL600908,CHEMBL600908
HGNC:2518,CTNS
chembl:CHEMBL166486,CHEMBL166486
chembl:CHEMBL3126832,OBP-801
chembl:CHEMBL1569494,CHEMBL1569494
chembl:CHEMBL159,VINBLASTINE
chembl:CHEMBL599896,CHEMBL599896
chembl:CHEMBL253896,XANTHOHUMOL
chembl:CHEMBL585654,CHEMBL585654
chembl:CHEMBL2107787,TESETAXEL
chembl:CHEMBL3353410,OSIMERTINIB
chembl:CHEMBL2106710,FADOLMIDINE HYDROCHLORIDE
HP:0010553,Oculogyric crisis
HP:0007054,Proximal hyperreflexia
chembl:CHEMBL2333546,MADOLIN U
chembl:CHEMBL3544927,L-21649
chembl:CHEMBL1503190,CHEMBL1503190
chembl:CHEMBL51931,"9,10-PHENANTHRENEQUINONE"
chembl:CHEMBL235668,TIPIRACIL
chembl:CHEMBL3545121,EPITINIB
HP:0000640,Gaze-evoked nystagmus
chembl:CHEMBL603,ZAFIRLUKAST
chembl:CHEMBL939,GEFITINIB
chembl:CHEMBL2108081,TRAFERMIN
chembl:CHEMBL605077,CHEMBL605077
chembl:CHEMBL1082,AMOXICILLIN
chembl:CHEMBL3545087,GSK159802
chembl:CHEMBL269538,HARMINE
chembl:CHEMBL287689,CHEMBL287689
MONDO:0003122,striatonigral degeneration
MONDO:0001751,cholestasis
chembl:CHEMBL596,FENTANYL
MONDO:0001815,extrapyramidal and movement disease
chembl:CHEMBL504256,FANGCHINOLINE
chembl:CHEMBL146710,CHEMBL146710
chembl:CHEMBL1201567,FILGRASTIM
chembl:CHEMBL1201165,QUINESTROL
chembl:CHEMBL1766,DESOXIMETASONE
chembl:CHEMBL582699,CHEMBL582699
chembl:CHEMBL1018,DIENESTROL
chembl:CHEMBL310798,TYRPHOSTIN 25
Reactome:R-BTA-611105,Respiratory electron transport
chembl:CHEMBL2093999,ISTAROXIME
chembl:CHEMBL427216,GLICLAZIDE
HP:0012651,Abasia
chembl:CHEMBL3545143,SR-13668
chembl:CHEMBL284348,DALFAMPRIDINE
MONDO:0011694,spinocerebellar ataxia type 15/16
chembl:CHEMBL1620,DIPHENHYDRAMINE HYDROCHLORIDE
chembl:CHEMBL306226,BENZIMIDAZOLE
HGNC:6990,MECP2
chembl:CHEMBL2146883,COBIMETINIB
chembl:CHEMBL127516,BUTAMBEN
chembl:CHEMBL28319,QUESTIOMYCIN B
chembl:CHEMBL40583,3-METHYLCHOLANTHRENE
Reactome:R-CFA-390666,Serotonin receptors
CHEBI:22720,benzodiazepine
chembl:CHEMBL1709,SERTRALINE HYDROCHLORIDE
chembl:CHEMBL502775,CHEMBL502775
chembl:CHEMBL66953,PURPUROGALLIN
chembl:CHEMBL1439833,CHEMBL1439833
chembl:CHEMBL601140,CHEMBL601140
HGNC:8788,PDE6D
HGNC:2076,CLN5
chembl:CHEMBL469036,ENNIATIN B
HGNC:253,ADH5
chembl:CHEMBL3833321,BAN2401
chembl:CHEMBL1725279,SP-600125
HP:0001336,Myoclonus
chembl:CHEMBL1200426,METHIXENE HYDROCHLORIDE
chembl:CHEMBL515,CHLORAMBUCIL
chembl:CHEMBL276832,HYDRALAZINE
chembl:CHEMBL59,DOPAMINE
CHEBI:46848,N-arylpiperazine
chembl:CHEMBL375673,CHEMBL375673
chembl:CHEMBL1989750,CHEMBL1989750
chembl:CHEMBL20883,TEGAFUR
MONDO:0009696,juvenile myoclonic epilepsy
chembl:CHEMBL1700,SOTALOL HYDROCHLORIDE
chembl:CHEMBL3545071,SERIBANTUMAB
chembl:CHEMBL113,CAFFEINE
chembl:CHEMBL119,TRIMETREXATE
chembl:CHEMBL77,ARTEMISIN
chembl:CHEMBL1200432,METHYLDOPATE HYDROCHLORIDE
HGNC:2084,CLPP
HGNC:145,ACTG2
HGNC:6407,KRAS
HGNC:4851,HTT
chembl:CHEMBL1320139,HELIOMYCIN
chembl:CHEMBL565612,SOTRASTAURIN
chembl:CHEMBL58,MITOXANTRONE
chembl:CHEMBL323356,CHEMBL323356
UPHENO:0081739,increased reflex in pectoral complex
chembl:CHEMBL601719,CRIZOTINIB
chembl:CHEMBL313737,CHEMBL313737
chembl:CHEMBL85194,CHEMBL85194
HGNC:2348,CREBBP
chembl:CHEMBL1201753,PITAVASTATIN
chembl:CHEMBL2103829,FAXELADOL
chembl:CHEMBL1098658,YANGONIN
chembl:CHEMBL3747513,CB-5083
MONDO:0005134,experimental autoimmune encephalomyelitis
chembl:CHEMBL139935,CHEMBL139935
chembl:CHEMBL1009,LEVODOPA
chembl:CHEMBL1257092,CHEMBL1257092
chembl:CHEMBL16751,CHEMBL16751
chembl:CHEMBL528694,CHEMBL528694
HGNC:2073,TPP1
chembl:CHEMBL142635,NAFTOPIDIL
chembl:CHEMBL96926,THAPSIGARGIN
MONDO:0016621,juvenile Huntington disease
chembl:CHEMBL578915,CHEMBL578915
chembl:CHEMBL3545000,MK-2201
chembl:CHEMBL1200323,LABETALOL HYDROCHLORIDE
chembl:CHEMBL535331,CHEMBL535331
chembl:CHEMBL2108738,NIVOLUMAB
HP:0010869,Asynergia
chembl:CHEMBL538542,CHEMBL538542
chembl:CHEMBL288174,CHEMBL288174
chembl:CHEMBL263094,CARMINIC ACID
chembl:CHEMBL1651906,STREPTOZOCIN
chembl:CHEMBL3544931,TAK-659
chembl:CHEMBL528807,CHEMBL528807
chembl:CHEMBL3545366,VOXTALISIB
chembl:CHEMBL17423,VESNARINONE
chembl:CHEMBL601547,CHEMBL601547
chembl:CHEMBL295316,PLUMBAGIN
chembl:CHEMBL117,CHRYSIN
chembl:CHEMBL1096,AMLEXANOX
chembl:CHEMBL341898,"(R,S)-INDATRALINE"
chembl:CHEMBL265502,SURAMIN
chembl:CHEMBL1201022,PHENAZOPYRIDINE HYDROCHLORIDE
chembl:CHEMBL1567571,CHEMBL1567571
chembl:CHEMBL586135,CHEMBL586135
chembl:CHEMBL3545150,AZM-475271
chembl:CHEMBL20,ACETAZOLAMIDE
chembl:CHEMBL589258,CHEMBL589258
CHEBI:3992,cyclic ketone
chembl:CHEMBL250450,ISOQUERCETIN
chembl:CHEMBL311226,CASTANOSPERMINE
chembl:CHEMBL1454,LEVAMISOLE
chembl:CHEMBL1212972,NANAOMYCIN
chembl:CHEMBL58752,PIMONIDAZOLE
chembl:CHEMBL3301622,GILTERITINIB
chembl:CHEMBL601364,CHEMBL601364
chembl:CHEMBL591864,CHEMBL591864
HGNC:130,ACTA2
chembl:CHEMBL190,THEOPHYLLINE
CHEBI:18946,delta-lactone
wikidata:Q3997863,ADO-TRASTUZUMAB EMTANSINE
chembl:CHEMBL546597,CHEMBL546597
chembl:CHEMBL3137343,PEMBROLIZUMAB
Reactome:R-CEL-390651,Dopamine receptors
chembl:CHEMBL776,METAPROTERENOL
chembl:CHEMBL1091250,INDIGOTINDISULFONATE
chembl:CHEMBL448515,"2,6-DIMETHOXYQUINONE"
HGNC:463,AMFR
chembl:CHEMBL1900528,TIOTROPIUM
chembl:CHEMBL2109391,MDX-447
chembl:CHEMBL649,NADOLOL
chembl:CHEMBL521,IBUPROFEN
chembl:CHEMBL312487,CHEMBL312487
chembl:CHEMBL220492,TOPIRAMATE
chembl:CHEMBL434200,TERTATOLOL
chembl:CHEMBL2105662,LOMITAPIDE MESYLATE
chembl:CHEMBL225072,PEMETREXED
CHEBI:59770,cyclic acetal
chembl:CHEMBL1200329,TIZANIDINE HYDROCHLORIDE
chembl:CHEMBL2109602,IMC-3C5
HGNC:694,ARL3
UPHENO:0080591,abnormal irritability behavior
CHEBI:25698,ether
chembl:CHEMBL1940832,MILVETEROL
chembl:CHEMBL606532,CHEMBL606532
chembl:CHEMBL1493528,CHEMBL1493528
chembl:CHEMBL388978,STAUROSPORINE
chembl:CHEMBL215152,AZD-1152-HQPA
chembl:CHEMBL217354,CHEMBL217354
chembl:CHEMBL1362503,CHEMBL1362503
chembl:CHEMBL4298021,ZAGOTENEMAB
chembl:CHEMBL487046,CHEMBL487046
chembl:CHEMBL3545069,PELAREOREP
chembl:CHEMBL2141296,IXAZOMIB
HGNC:16031,RNF31
HP:0002360,Sleep disturbance
chembl:CHEMBL1743052,OPORTUZUMAB MONATOX
HP:0007295,Chaotic rapid conjugate ocular movements
chembl:CHEMBL1711,ISOPROTERENOL HYDROCHLORIDE
chembl:CHEMBL1097999,E-6201
chembl:CHEMBL576982,QUIZARTINIB
HGNC:3811,FOXG1
chembl:CHEMBL679,EPINEPHRINE
chembl:CHEMBL715,OLANZAPINE
chembl:CHEMBL605846,OLODATEROL
HGNC:9325,PPT1
MONDO:0014144,autosomal recessive limb-girdle muscular dystrophy type R18
chembl:CHEMBL1731432,CHEMBL1731432
HGNC:678,ARHGDIA
HP:0002317,Unsteady gait
CHEBI:35610,antineoplastic agent
MONDO:0003939,muscle tissue disorder
HGNC:3748,FLG
chembl:CHEMBL499608,NAKIJIQUINONES H
chembl:CHEMBL3545365,ALTIRATINIB
chembl:CHEMBL414157,TONAPOFYLLINE
chembl:CHEMBL411907,SONOLISIB
chembl:CHEMBL1200492,NEFAZODONE HYDROCHLORIDE
HP:0001417,X-linked inheritance
chembl:CHEMBL1503729,CHEMBL1503729
chembl:CHEMBL1233528,VOLASERTIB
HP:0031960,Arm dystonia
HGNC:8859,PEX6
chembl:CHEMBL44657,ETOPOSIDE
MONDO:0100339,Friedreich ataxia
chembl:CHEMBL415324,TRANILAST
chembl:CHEMBL3989941,TINOSTAMUSTINE
chembl:CHEMBL599098,CHEMBL599098
chembl:CHEMBL282575,ESTRADIOL BENZOATE
HGNC:10548,ATXN1
MONDO:0012450,spinocerebellar ataxia type 28
MONDO:0009133,"cerebellar ataxia, intellectual disability, and dysequilibrium"
chembl:CHEMBL76904,TYRPHOSTIN 23
MONDO:0042980,Westphal disease
chembl:CHEMBL1950651,EVODENOSON
HGNC:8587,PAICS
chembl:CHEMBL1218,RAMELTEON
chembl:CHEMBL3545285,XL-999
chembl:CHEMBL63440,ALOXISTATIN
HGNC:11920,FAS
chembl:CHEMBL313972,MASOPROCOL
chembl:CHEMBL31088,DEOXIEPINEPHRINE
chembl:CHEMBL486004,KLUGINE
chembl:CHEMBL486706,CHEMBL486706
chembl:CHEMBL51085,EBSELEN
chembl:CHEMBL505251,KERACYANIN
chembl:CHEMBL126077,INDIRUBIN-3-MONOXIME
chembl:CHEMBL249448,CHEMBL249448
chembl:CHEMBL853,ZALCITABINE
HP:0001250,Seizure
chembl:CHEMBL2029988,CEP-32496
chembl:CHEMBL1588679,CHEMBL1588679
HP:0000006,Autosomal dominant inheritance
chembl:CHEMBL1086440,TRICLABENDAZOLE
chembl:CHEMBL2063681,CHEMBL2063681
chembl:CHEMBL72,DESIPRAMINE
chembl:CHEMBL1609016,CHEMBL1609016
chembl:CHEMBL2028663,DABRAFENIB
chembl:CHEMBL2146126,LITHIUM
chembl:CHEMBL76589,CHEMBL76589
chembl:CHEMBL3545272,LAS190792
chembl:CHEMBL458178,KASANOSIN A
chembl:CHEMBL536375,CHEMBL536375
chembl:CHEMBL2108324,OBLIMERSEN
chembl:CHEMBL2109389,IMGATUZUMAB
HP:0002145,Frontotemporal dementia
chembl:CHEMBL64391,ITRACONAZOLE
HGNC:236,ADCY5
chembl:CHEMBL53898,CHEMBL53898
chembl:CHEMBL506,PRIMAQUINE
chembl:CHEMBL258940,FALNIDAMOL
chembl:CHEMBL534535,CHEMBL534535
chembl:CHEMBL454580,GARCINONE E
chembl:CHEMBL1200798,TRAZODONE HYDROCHLORIDE
GO:0033300,dehydroascorbic acid transmembrane transporter activity
chembl:CHEMBL1743049,OLARATUMAB
chembl:CHEMBL63,ROLIPRAM
chembl:CHEMBL600747,CHEMBL600747
chembl:CHEMBL598903,CHEMBL598903
chembl:CHEMBL3623290,AZD-3759
chembl:CHEMBL592068,CHEMBL592068
chembl:CHEMBL463574,RATANIAPHENOL II
chembl:CHEMBL85139,RUTAECARPINE
HP:0010542,Vestibular nystagmus
chembl:CHEMBL486005,ISOCEPHAELINE
chembl:CHEMBL2105728,CRENOLANIB
HP:0006896,Hypnopompic hallucinations
MONDO:0004114,urinary bladder small cell neuroendocrine carcinoma
chembl:CHEMBL129795,ISOLIQUIRITIGENIN
HP:0000639,Nystagmus
chembl:CHEMBL2002487,CHEMBL2002487
chembl:CHEMBL1927048,CHEMBL1927048
HP:0007979,Gaze-evoked horizontal nystagmus
chembl:CHEMBL300138,ENZASTAURIN
chembl:CHEMBL388342,BOLDINE
chembl:CHEMBL348436,CIRSIMARITIN
MONDO:0008383,rheumatoid arthritis
chembl:CHEMBL3,NICOTINE
MONDO:0007435,dentatorubral-pallidoluysian atrophy
chembl:CHEMBL1518,PROPYLTHIOURACIL
HGNC:753,ASNS
chembl:CHEMBL1201213,ISOETHARINE
chembl:CHEMBL375293,CHEMBL375293
chembl:CHEMBL1469,PHENYLBUTANOIC ACID
chembl:CHEMBL723,CARVEDILOL
chembl:CHEMBL3545271,PBF-999
chembl:CHEMBL60718,TPCK
chembl:CHEMBL3301610,ABEMACICLIB
chembl:CHEMBL1201260,BETHANIDINE
chembl:CHEMBL1403281,ERGOCRYPTINE
chembl:CHEMBL1200791,OXYMETAZOLINE HYDROCHLORIDE
chembl:CHEMBL507026,THIOLUTIN
MONDO:0014410,spinocerebellar ataxia type 37
chembl:CHEMBL1594935,CYSTAMINE DIHYDROCHLORIDE
HP:0010533,Spasmus nutans
chembl:CHEMBL1453126,CHEMBL1453126
chembl:CHEMBL1480,FELODIPINE
chembl:CHEMBL1131,ACITRETIN
HGNC:644,AR
HP:0000007,Autosomal recessive inheritance
chembl:CHEMBL3397300,CHEMBL3397300
chembl:CHEMBL49642,INDIBULIN
MONDO:0002492,acute kidney failure
chembl:CHEMBL578512,CHEMBL578512
chembl:CHEMBL592445,GEDATOLISIB
chembl:CHEMBL3545261,BRONTICTUZUMAB
chembl:CHEMBL109480,TANESPIMYCIN
chembl:CHEMBL3545088,PUQUITINIB
HP:0031007,Orofacial action-specific dystonia induced by speech
chembl:CHEMBL7917,TYRPHOSTIN AG-1478
HGNC:9086,PLP1
chembl:CHEMBL242171,CHEMBL242171
chembl:CHEMBL1534034,CHEMBL1534034
chembl:CHEMBL513116,N-AMINOHEXYL-5-CHLORO-1-NAPTHALENESULFONAMIDE HYDROCHLORIDE
chembl:CHEMBL586061,CHEMBL586061
HGNC:32,ABCA2
MONDO:0014557,ataxia - oculomotor apraxia type 4
chembl:CHEMBL3545154,POZIOTINIB
chembl:CHEMBL30327,"2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN"
chembl:CHEMBL501867,VINCRISTINE SULFATE
chembl:CHEMBL3545085,XL-228
chembl:CHEMBL552212,LEXIBULIN
chembl:CHEMBL12089,BERBERINE CHLORIDE
HGNC:6871,MAPK1
chembl:CHEMBL2333543,CHEMBL2333543
chembl:CHEMBL18442,PLERIXAFOR
chembl:CHEMBL475251,R-406
chembl:CHEMBL505807,CHEMBL505807
chembl:CHEMBL2103875,TRAMETINIB
chembl:CHEMBL1909300,HEPARIN
chembl:CHEMBL1201573,OPRELVEKIN
CHEBI:71337,minocycline(1-)
MONDO:0005096,squamous cell carcinoma
chembl:CHEMBL1064,SIMVASTATIN
chembl:CHEMBL1321401,CHEMBL1321401
HP:0001310,Dysmetria
chembl:CHEMBL15928,GR-127935
MONDO:0005402,lymphoid leukemia
chembl:CHEMBL338474,HELENALIN
chembl:CHEMBL225230,R-N-PROPYLNORAPOMORPHINE
chembl:CHEMBL1503,OMEPRAZOLE
chembl:CHEMBL1079742,ERLOTINIB HYDROCHLORIDE
chembl:CHEMBL1392894,CHEMBL1392894
chembl:CHEMBL202721,CHEMBL202721
chembl:CHEMBL287542,RAFOXANIDE
chembl:CHEMBL467,HYDROXYUREA
chembl:CHEMBL349803,PIRETANIDE
MONDO:0003233,essential tremor
chembl:CHEMBL514,LOMUSTINE
chembl:CHEMBL1256364,CHEMBL1256364
chembl:CHEMBL2105160,NAMINIDIL
chembl:CHEMBL1200667,ENCLOMIPHENE CITRATE
chembl:CHEMBL482967,CYC-116
HGNC:735,ASAH1
MONDO:0005311,atherosclerosis
chembl:CHEMBL510279,DIHYDROXANTHOHUMOL
chembl:CHEMBL1703,METFORMIN HYDROCHLORIDE
chembl:CHEMBL122,ROFECOXIB
HGNC:34,ABCA4
chembl:CHEMBL503,LOVASTATIN
chembl:CHEMBL285819,CHEMBL285819
chembl:CHEMBL714,ALBUTEROL
HP:0001288,Gait disturbance
chembl:CHEMBL3545009,PBF-509
chembl:CHEMBL1200930,RABEPRAZOLE SODIUM
chembl:CHEMBL1770916,NIROGACESTAT
chembl:CHEMBL1073,GLIPIZIDE
chembl:CHEMBL506871,VELIPARIB
chembl:CHEMBL4298113,BAMOSIRAN
chembl:CHEMBL3301595,DASOTRALINE
chembl:CHEMBL4297366,CG-200745
chembl:CHEMBL3545322,PANULISIB
chembl:CHEMBL1200812,METAPROTERENOL SULFATE
HP:0001347,Hyperreflexia
MONDO:0021042,glioma
HGNC:315,AFG3L2
chembl:CHEMBL578890,CHEMBL578890
chembl:CHEMBL3544983,TESEVATINIB
MONDO:8000012,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1"
HGNC:11007,SLC2A3
HGNC:7989,NRAS
UPHENO:0081742,increased reflex in patella
chembl:CHEMBL1326877,DIOXYBENZONE
chembl:CHEMBL363648,TAK-715
GO:0015755,fructose transmembrane transport
chembl:CHEMBL606460,CHEMBL606460
HGNC:18224,ZRANB1
chembl:CHEMBL221137,EMBELIN
chembl:CHEMBL1200444,PIRBUTEROL ACETATE
chembl:CHEMBL486196,ANGUSTIBALIN
chembl:CHEMBL418134,BUNITROLOL
chembl:CHEMBL586031,CHEMBL586031
chembl:CHEMBL153479,AMBROXOL
chembl:CHEMBL252417,CHEMBL252417
chembl:CHEMBL490129,SANGUINARIUM CHLORIDE
chembl:CHEMBL580340,CHEMBL580340
chembl:CHEMBL1492044,FLUORESCEIN DIACETATE
chembl:CHEMBL105442,CI-1040
HGNC:144,ACTG1
chembl:CHEMBL118218,IROFULVEN
chembl:CHEMBL40275,ALOE-EMODIN
chembl:CHEMBL1095777,INDACATEROL
MONDO:0004970,adenocarcinoma
chembl:CHEMBL83527,PTEROSTILBENE
chembl:CHEMBL253570,GOSSYPETIN
HP:0000752,Hyperactivity
chembl:CHEMBL2103842,VARLITINIB
chembl:CHEMBL1201748,CABAZITAXEL
chembl:CHEMBL4297451,XL-888
MONDO:0015548,Huntington disease-like syndrome
chembl:CHEMBL259084,MLN-8054
chembl:CHEMBL4297190,SURUFATINIB
chembl:CHEMBL362223,CHEMBL362223
chembl:CHEMBL604321,CHEMBL604321
MONDO:0002419,transient tic disorder
Reactome:R-DRE-611105,Respiratory electron transport
chembl:CHEMBL600738,CHEMBL600738
chembl:CHEMBL928,DANTROLENE SODIUM
chembl:CHEMBL54,HALOPERIDOL
MONDO:0008695,chorea-acanthocytosis
MONDO:0011811,autosomal recessive cerebellar ataxia-saccadic intrusion syndrome
chembl:CHEMBL411,DIETHYLSTILBESTROL
chembl:CHEMBL588234,CHEMBL588234
chembl:CHEMBL1743013,ENSITUXIMAB
HGNC:5045,HNRNPL
chembl:CHEMBL430893,(-)-ROLIPRAM
chembl:CHEMBL191003,JNJ-7706621
chembl:CHEMBL3786343,OLMUTINIB
HGNC:348,AHR
chembl:CHEMBL2110730,POMAGLUMETAD METHIONIL
chembl:CHEMBL1256388,CYSTAMINE HYDROCHLORIDE
chembl:CHEMBL4298120,FUTIBATINIB
chembl:CHEMBL1256291,CHEMBL1256291
chembl:CHEMBL1173055,RUCAPARIB
chembl:CHEMBL4216467,RIPRETINIB
HGNC:3033,ATN1
chembl:CHEMBL311489,CHEMBL311489
chembl:CHEMBL3989914,GLESATINIB
chembl:CHEMBL465226,GEDUNIN
chembl:CHEMBL300982,LICOFELONE
chembl:CHEMBL1743051,ONARTUZUMAB
chembl:CHEMBL3545025,INSM-18
chembl:CHEMBL1201550,DENILEUKIN DIFTITOX
chembl:CHEMBL81,RALOXIFENE
chembl:CHEMBL1201156,NORTRIPTYLINE HYDROCHLORIDE
HGNC:2531,CTSF
chembl:CHEMBL50,QUERCETIN
chembl:CHEMBL480356,CHEMBL480356
chembl:CHEMBL3545244,ALLITINIB
HGNC:7608,MYO9A
HP:0031959,Leg dystonia
chembl:CHEMBL157844,PUUPEHENONE
chembl:CHEMBL247471,CHEMBL247471
chembl:CHEMBL4298088,CETUXIMAB SAROTALOCAN
chembl:CHEMBL730,NITROGLYCERIN
chembl:CHEMBL1692,IMIPRAMINE HYDROCHLORIDE
chembl:CHEMBL3120215,OSI-027
chembl:CHEMBL284906,NICORANDIL
chembl:CHEMBL1171837,PONATINIB
chembl:CHEMBL397420,ACENOCOUMAROL
chembl:CHEMBL445,NORTRIPTYLINE
HGNC:11537,TAF4
chembl:CHEMBL1214827,ONALESPIB
chembl:CHEMBL1200787,PHENOXYBENZAMINE HYDROCHLORIDE
chembl:CHEMBL588038,CHEMBL588038
chembl:CHEMBL43612,JUGLONE
chembl:CHEMBL127421,CHEMBL127421
chembl:CHEMBL586024,CHEMBL586024
chembl:CHEMBL1574420,CHEMBL1574420
MONDO:0009419,Woodhouse-Sakati syndrome
chembl:CHEMBL3360203,PILARALISIB
chembl:CHEMBL417,EPIRUBICIN
chembl:CHEMBL1200833,DIPIVEFRIN HYDROCHLORIDE
chembl:CHEMBL585,TRIAMTERENE
HP:0000496,Abnormality of eye movement
chembl:CHEMBL3188267,CAPMATINIB
chembl:CHEMBL3989759,EXATECAN MESYLATE
CHEBI:50694,minocycline
chembl:CHEMBL1549738,CHEMBL1549738
HGNC:4115,GALC
chembl:CHEMBL502835,NINTEDANIB
chembl:CHEMBL88,CYCLOPHOSPHAMIDE
chembl:CHEMBL235891,CHEMBL235891
HGNC:31399,SLC6A17
MONDO:0018945,McLeod neuroacanthocytosis syndrome
chembl:CHEMBL1343568,CHEMBL1343568
chembl:CHEMBL1489769,LASALOCID A SODIUM
chembl:CHEMBL1415851,CHEMBL1415851
chembl:CHEMBL172439,SLAZINIC ACID
HP:0030190,Oral motor hypotonia
chembl:CHEMBL3989695,REGADENOSON
chembl:CHEMBL1086377,CHEMBL1086377
chembl:CHEMBL598663,CHEMBL598663
GO:0005353,fructose transmembrane transporter activity
chembl:CHEMBL1550879,MECETRONIUM
chembl:CHEMBL1797713,CHEMBL1797713
chembl:CHEMBL164,MYRICETIN
chembl:CHEMBL3545427,CM-082
chembl:CHEMBL289351,FOSBRETABULIN DISODIUM
HP:0006915,Inability to walk by childhood/adolescence
chembl:CHEMBL446452,ARUNDINE
chembl:CHEMBL52,NORDIHYDROGUAIARETIC ACID
chembl:CHEMBL1372046,CHEMBL1372046
chembl:CHEMBL1389,LEVONORGESTREL
chembl:CHEMBL83,TAMOXIFEN
chembl:CHEMBL2108029,ERTUMAXOMAB
chembl:CHEMBL165790,IPRIFLAVONE
chembl:CHEMBL515617,CHEMBL515617
chembl:CHEMBL2220486,LUCITANIB
chembl:CHEMBL1743062,RAMUCIRUMAB
chembl:CHEMBL838,BENAZEPRIL
chembl:CHEMBL458765,CHEMBL458765
chembl:CHEMBL154580,CHEMBL154580
HGNC:7905,NPHP1
chembl:CHEMBL1368696,CHEMBL1368696
chembl:CHEMBL290106,BITHIONOL
chembl:CHEMBL1440119,IRIGINOL HEXAACEATATE
chembl:CHEMBL4297813,PRI-724
HGNC:10555,ATXN2
chembl:CHEMBL4085457,PF-06651600
HGNC:4651,GTF2E2
chembl:CHEMBL521589,BAMBUTEROL
chembl:CHEMBL325041,BORTEZOMIB
chembl:CHEMBL17205,CYCLOVALONE
chembl:CHEMBL4078100,AZD-5153
chembl:CHEMBL3301612,ENCORAFENIB
chembl:CHEMBL590706,CHEMBL590706
chembl:CHEMBL608,PROBUCOL
chembl:CHEMBL509999,AROMOLINE
chembl:CHEMBL2105719,DACOMITINIB
chembl:CHEMBL1222251,INOSITOL
HP:0000727,Frontal lobe dementia
chembl:CHEMBL1963502,PKI-166
HP:0034345,Mendelian inheritance
chembl:CHEMBL2035187,PACRITINIB
chembl:CHEMBL1201013,OLSALAZINE SODIUM
chembl:CHEMBL586937,CHEMBL586937
chembl:CHEMBL415879,PHENANTHROLINE
chembl:CHEMBL49080,CLENBUTEROL
MONDO:0007803,multiple system atrophy
chembl:CHEMBL1591258,"3,4-DIMETHOXYDALBERGIONE"
chembl:CHEMBL1532097,DIHYDRODAPHNODORIN B
chembl:CHEMBL464859,NECA
chembl:CHEMBL643,PROMETHAZINE
chembl:CHEMBL1256686,CALCIMYCIN
chembl:CHEMBL129857,AS-602868
chembl:CHEMBL741,LAMOTRIGINE
chembl:CHEMBL418068,RHEIN
chembl:CHEMBL21731,MAPROTILINE
chembl:CHEMBL472437,KAMEBANIN
chembl:CHEMBL1516890,GW441756X
chembl:CHEMBL1327172,CHEMBL1327172
chembl:CHEMBL593,DELAVIRDINE
chembl:CHEMBL3545135,NV-128
chembl:CHEMBL485756,CHEMBL485756
chembl:CHEMBL77675,CHEMBL77675
chembl:CHEMBL500,PINDOLOL
chembl:CHEMBL224214,CARBONYL CYANIDE M-CHLOROPHENYLHYDRAZONE
chembl:CHEMBL2089002,DEMETHYLWEDELOLACTONE
chembl:CHEMBL954,ENCLOMIPHENE
HGNC:225,ADAR
chembl:CHEMBL3544964,RAVOXERTINIB
chembl:CHEMBL585502,CHEMBL585502
GO:0043204,perikaryon
chembl:CHEMBL487805,SCUTELLARIN
chembl:CHEMBL70582,CHEMBL70582
chembl:CHEMBL57,NEVIRAPINE
MONDO:0100096,COVID-19
HGNC:851,ATP6V1A
CHEBI:50733,nutraceutical
chembl:CHEMBL1256391,PIRFENIDONE
HGNC:24624,SIL1
chembl:CHEMBL1256137,CYSTEAMINE HYDROCHLORIDE
chembl:CHEMBL4297163,MUPARFOSTAT
chembl:CHEMBL1627429,CHEMBL1627429
chembl:CHEMBL3545134,LY-2780301
chembl:CHEMBL1200574,SODIUM CHLORIDE
chembl:CHEMBL129,ZIDOVUDINE
chembl:CHEMBL379975,CHEMBL379975
MONDO:0021095,parkinsonian disorder
chembl:CHEMBL527584,CHEMBL527584
HP:0006801,Hyperactive deep tendon reflexes
chembl:CHEMBL582715,CHEMBL582715
chembl:CHEMBL10878,AGOMELATINE
chembl:CHEMBL1934283,OPHIOBOLIN O
chembl:CHEMBL187266,TANSHINONE IIA
chembl:CHEMBL74852,CHEMBL74852
chembl:CHEMBL4297422,RG-4733
HGNC:7463,MTNR1A
chembl:CHEMBL1546223,CHEMBL1546223
chembl:CHEMBL601757,CHEMBL601757
chembl:CHEMBL1079,TIZANIDINE
chembl:CHEMBL4297416,PF-4191834
chembl:CHEMBL655,MIDAZOLAM
HGNC:7106,ATXN3
chembl:CHEMBL3545300,CP-459632
HP:0020035,Lower limb dysmetria
GO:0015757,galactose transmembrane transport
HGNC:620,APP
chembl:CHEMBL574737,UCN-01
chembl:CHEMBL2094456,CHEMBL2094456
chembl:CHEMBL3544960,AT-13148
chembl:CHEMBL250892,(R)-MELPHALAN
chembl:CHEMBL399530,CHEMBL399530
chembl:CHEMBL498,CHLORPROPAMIDE
wikidata:Q21044462,DEL-22379
chembl:CHEMBL582478,CHEMBL582478
chembl:CHEMBL74926,PHENSERINE
chembl:CHEMBL541400,CHEMBL541400
chembl:CHEMBL597452,CHEMBL597452
chembl:CHEMBL452231,TENIPOSIDE
HP:0006977,Deficit in grammar
chembl:CHEMBL4297417,"PHENSERINE, (+)-"
CHEBI:145565,macrolide lactam
chembl:CHEMBL1236962,OMIPALISIB
chembl:CHEMBL580,LORAZEPAM
HGNC:263,ADORA2A
chembl:CHEMBL1200374,EXEMESTANE
Reactome:R-CEL-390650,Histamine receptors
chembl:CHEMBL1079175,MK-2206
chembl:CHEMBL514409,HESPERADIN
chembl:CHEMBL363614,BENZOFURAN
chembl:CHEMBL802,MINOXIDIL
HGNC:23166,PNPT1
chembl:CHEMBL1337,NITISINONE
HP:0000708,Atypical behavior
HGNC:535,ANXA11
chembl:CHEMBL461308,MANASSANTIN B
Reactome:R-CEL-500753,Pyrimidine biosynthesis
chembl:CHEMBL1372341,PIRENOXINE
chembl:CHEMBL2109271,MDX-210
CHEBI:16919,creatine
chembl:CHEMBL226507,SINENSETIN
chembl:CHEMBL84685,CHEMBL84685
chembl:CHEMBL4297755,FP-1039
chembl:CHEMBL428690,ALVOCIDIB
chembl:CHEMBL1200339,PHENYLEPHRINE HYDROCHLORIDE
chembl:CHEMBL600734,CHEMBL600734
chembl:CHEMBL1173445,LARGAZOLE
chembl:CHEMBL782,TOLBUTAMIDE
chembl:CHEMBL471004,CHEMBL471004
chembl:CHEMBL582439,ZAMPANOLIDE
HGNC:9935,RCN2
chembl:CHEMBL1224755,CHEMBL1224755
chembl:CHEMBL2109328,IMC-EB10
chembl:CHEMBL1200660,ISOSORBIDE
chembl:CHEMBL3039540,ADUCANUMAB
chembl:CHEMBL490125,SCHISANHENOL
chembl:CHEMBL1802135,PROTUBOXEPIN A
HP:0002355,Difficulty walking
chembl:CHEMBL2105866,PROTOPORPHYRIN DISODIUM
chembl:CHEMBL260311,CHEMBL260311
chembl:CHEMBL532,ERYTHROMYCIN
HGNC:9508,PSEN1
chembl:CHEMBL428496,WORTMANNIN
chembl:CHEMBL530280,CHEMBL530280
HP:0032104,Saccadic oscillation
chembl:CHEMBL1502,PANTOPRAZOLE
chembl:CHEMBL590691,CHEMBL590691
